+917069000000 info@cims.org

RESEARCH

CIMS Hospital
Care Institute of Medical Sciences
Off Science City Road, Sola, Ahmedabad – 380060
Gujarat, INDIA

24x7 Helpline +91 70 69 00 00 00
Phone: +91 79 2771 2771 or 72
Fax: +91 79 2771 2770
Mobile: +91 98250 66664 or +91 98250 66668
Ambulance: +91 98244 50000
Email: info@cims.org

Learn all about Research Activities at CIMS Hospital in Ahmedabad.

CIMS Research Center, which has been participating in the Clinical trials since more than a decade & having experience of more than 120 trials (phase III,phase lV,registries and device).The CIMS Research center is well established department which offers suitable infrastructure as per the clinical industry norms, highly experienced team of Doctors & full time clinical research coordinators dedicated to conduct the clinical trials flawlessly.

We are having experience of conducting clinical trials in various therapeutics areas like Cardiology, Pulmonology, Oncology, Orthopedics, & Gastroenterology.

Clinical Trials

    1. RUBY registry (For India) (2002). To evaluate Percusurge / Guardwire Distal Protection Device (Presented by Dr. Aman, Switzerland). Presented TCT October 2003, Sponsored by Medtronics Pvt. Ltd. Study Completed.
    2. Extract-TIMI 25 Multicentre multinational Trial (2003). Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction –Study 25. Presented at ACC 06. Study Completed.
    3. To Evaluate the Efficacy and Safety of Fondaparinux versus Enoxaparin in the Acute Treatment of Unstable Angina or Non ST-Segment Elevation Myocardial Infarction Acute Coronary Syndromes. Presented in ESC, Stockholm, Sweden.Study Completed.
    4. OASIS-6 Trial (2004). To Evaluate the Efficacy and Safety of Fondaparinux Sodium versus Control Therapy and Glucose-Insulin-Potassium Infusion versus Control in Broad Range in Patients with ST -Segment Elevation Acute Myocardial Infarction. Presented at ACC 06. Trial Complete
    5. TRUST Trial (2004). To Evaluate the Safety and Efficacy of Intravenous Remodulin® in Patients (in India) with Pulmonary Arterial Hypertension (PAH) in 12-week. Study Completed.
    6. Paediatric Hypertension Trial (2005). Dose Ranging Study to Evaluate the Safety and Efficacy of Olmesartan medoxomil in Children and Adolescents with Hypertension. Study Completed.
    7. Hypercholesterol study (NK-104-301) at The Heart Care Clinic/CIMS (2005). Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration) in Patients with Primary Hypercholesterolemia or Combined Dyslipidemia. Study Completed.
    8. Neovasc Reducer™ Pilot Study, First in human: (2005). To Evaluate the Safety of the Neovasc Reducer™ in the Treatment of Ischemic Heart Disease (IHD) Controlled Narrowing of the Coronary Sinus. Presented at TCT, 2005. Study Completed.
    9. PAPIRUS Trial: Pilot Study, First in Human: Apollo Hospital (2005). Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (REMON Device). Study Completed.
    10. Export study (2006). Flow Improvement in Patients with Acute Myocardial Infarction Undergoing Either Conventional Stenting or a Strategy of Primary Aspiration Followed by Stenting Using the Export® Aspiration Catheter: a Prospective, Randomized, Controlled Study. Study Completed.
    11. Five registry (for India) (2006). To Evaluate the ‘Real World’ Clinical Performance of the Medtronic Endeavor™ ABT-578 Eluting Coronary Stent System. Study Completed.
    12. RELY study (2006). Randomized Evaluation of Long Term Anticoagulant TherapComparing Efficacy and Safety of Two Blinded Doses of Dabigatran etexilate with Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation : Prospective, Multi-Centre, Parallel Group, Non-Inferiority Trial. Study Completed.
    13. RE-Cover (2006): A Phase III, Randomised, Double Blind, Parallel-group Study of the Efficacy and Safety of Oral Dabigatran Etexilate 150 mg Twice Daily Compared to Warfarin (INR 2.0-3.0) for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism (VTE), Following Initial Treatment (5-10 Days) With a Parenteral Anticoagulant Approved for This Indication: Study Completed.
    14. Re-Medy (2006): A Phase III, Randomised, Multicenter, Double-blind, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of Oral Dabigatran Etexilate (150 mg Bid) Compared to Warfarin (INR 2.0-3.0) for the Secondary Prevention of Venous Thromboembolism: Study Completed.
    15. RELY ABLE study (2009). Long Term Multi-center Extension of Dabigatran Treatment in Patients with Atrial Fibrillation Who Completed the RELY Trial and a Cluster Randomized Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes. Study Completed.
    16. Hypercholesterolemia study (NK-104-307) at The Heart Care Clinic/CIMS (2006). Open Label, Long-Term (1year) Extension Study of Pitavastatin 4 mg QD in Patients with Primary Hypercholesterolemia or Combined Dyslipidemia. Study Completed.
    17. e-SELECT Registry (2007). The e-SELECT Registry: A Multicenter Post Marketing. Study Completed.
    18. Early ACS trial (2007). Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS). Study Completed.
    19. PLATO trial (2007). A Randomized, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compares with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of Platelet inhibition and Patient Outcomes.] Study Completed.
    20. OASIS- 7 trial (2007). Randomized, Multinational, Double-blind study, comparing a High Loading Dose Regimen of Clopidogrel versus Standard Dose in Patients with Unstable Angina or Non-ST Segment Elevation Myocardial Infarction Managed with an Early Invasive Strategy. Study Completed.
    21. Ovalum: New Guidewire (2007). First in Man: A Feasibility Study to Evaluate Safety and Efficacy of New Guidewire for Crossing Total Occlusions in Coronary Arteries. Study Completed.
    22. Paediatric Hypertension Trial, the Heart Care Clinic/CIMS, Ahmedabad (2007). A Randomized, Double blind, Placebo-Controlled, Multicenter, Parallel Study Assessing the Efficacy, Safety, and Dose Response of Ramipril for the Treatment of Hypertension in Children and Adolescents. Study Completed.
    23. Aristotle Trial at The Heart Care Clinic/CIMS, Ahmedabad (2007). Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation: Active Controlled Randomized Double Blind Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Subject with Non-valvular Atrial Fibrillation. Study Completed.
    24. Rocket Trial at The Heart Care Clinic/CIMS, Ahmedabad (2007). Multicenter, Randomized, Double-blind – Dummy, Parallel-group, Non-inferiority Trial Comparing the Efficacy and Safety of Once-daily Oral Rivaroxaban (BAY 59-7939) with Adjusted-dose Oral Warfarin for the Prevention of Stroke and Non-central-nervous-system Systemic Embolism in Subjects with Non-valvular Atrial Fibrillation. Study Completed.
    25. PROTECT Trial (2007). Patient Related Outcomes with Endeavor versus Cypher Stenting Trial: Prospective, Multicenter, Randomized, Two-arm, Open-label Trial. Study Completed.
    26. TMC-CAN-05-02 (2007). A Clinical Trial Comparing Cangrelor to Clopidogrel in Subject who Require Percutaneous Coronary Intervention. Study Completed.
    27. TMC-CAN-05-03 (2008). A Clinical Trial Comparing Treatment with Cangrelor (in combination with usual care) to Usual Care in Subjects who Require Percutaneous Coronary Intervention. Study Completed.
    28. RELY AF Registry (2008).: Risk Factors, Treatments and Outcomes for Emergency Department Patients with Atrial Fibrillation in Multiple Regions of the World. Study Completed.
    29. CL (Ivabradine) at the Heart Care Clinic/CIMS (2008). Evaluation of the Anti-anginal Efficacy. Study Completed.
    30. RE-DEEM at The Heart Care Clinic/CIMS (2008). Randomized Dabigatran Etexilate Dose Finding Study in Patients with Acute Coronary Syndromes Post Index Event with Additional Risk Factors for Cardiovascular Complications also Receiving Aspirin and Clopidogrel: Multi-centre, Prospective, Placebo Controlled, and Group Dose Escalation Trial. Study Completed.
    31. Magellan Trial (2008). A Multicenter, Randomized, Parallel-group Efficacy Superiority Study in Hospitalize Medically Ill Patients Comparing Rivaroxaban with Enoxaparin. Study Completed.
    32. Borealis Trial at the Heart Care Clinic/CIMS Ahmedabad (2008). A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) with Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patient with Atrial Fibrillation. Study Completed.
    33. “A Phase 2, Double-Blind, Double-Dummy, Randomized, Parallel Group Dose Finding Study To Investigate The Safety And Tolerability Of YM150 In Subjects With Non-Vascular Atrial Fibrillation And To Compare The Safety And Tolerability With Warfarin.” (OPAL – 2): Completed
    34. Freedom-PAH at The Heart Care Clinic/CIMS. FREEDOM UT –15C Studies (TDE-PH-302 and TDE-PH-304) Conducted by United Therapeutics. Follow ups Ongoing.
    35. ORBIT – 1. Pilot Study to Evaluate the Safety & Performance or the Diamondback 360TM Orbit Atherectomy System in Treating De Novo Calcified Coronary Lesions – Orbit –I. Study Completed.
    36. AVERROES at the Heart Care Clinic/CIMS. CV 185-048: A Phase 3, Active (Aspirin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate the Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation. Study Completed.
    37. Red-HF at The Heart Care Clinic/CIMS. A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia –. Study Completed.
    38. TAK-442-202 at the Heart Care Clinic/CIMS. A Phase II, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects with Acute Coronary Syndrome. Study Completed.
    39. EISAI-202 at The Heart Care Clinic/CIMS. A Randomized, Double-Blind Placebo Controlled Study of the Safety and Tolerability of E5555 and its Effect on Clinical Event and Biomarkers in Patient with Non-ST Segment Elevation Acute Coronary Syndrome. Study Completed.
    40. E-Resolute at the Heart Care Clinic/CIMS. Evaluation of the Endeavor Resolute Zotarolimus -Eluting Coronary Stent System in a ‘Real World’ Patient Population. Study Completed.
    41. RIVAROXABAN at The Heart Care Clinic/CIMS. Randomized, Double Blind, Placebo Controlled, Event Driven, Multi-Center Study To Evaluate The Efficacy And Safety of Rivaroxaban in Subjects With Recent ACS. Study Completed.
    42. Pfizer PAH at The Heart Care Clinic/CIMS B1321001. A Phase 3, Multi-center, Randomized, Double Blind, Placebo Controlled, Safety and Efficacy Study of Sitaxsentan Sodium in Subjects with Pulmonary Arterial Hypertension. Study Completed.
    43. Pfizer PAH at The Heart Care Clinic/CIMSB1321002. A Phase 3, Multi Center, Open Label Study To Evaluate The Long Term Safety of Monotherapy Sitaxsentan Sodium And Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension. Study Completed.
    44. Pfizer PAH at The Heart Care Clinic/CIMSB1321003. A Phase 3, Multi Center, Randomized, Double Blind, Efficacy and Safety Study of Monotherapy Sitaxsentan Sodium versus Combination Therapy with Sitaxsentan Sodium and Sildenafil Citrate in Subjects with Pulmonary Arterial Hypertension who have Completed Study B1321001. Study Completed.
    45. LPL STABILITY at The Heart Care Clinic/CIMS. A Clinical Outcome Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Event (MACE).Study Completed.
    46. OASIS-8 at The Heart Care Clinic/CIMS. A Prospective Study Evaluating the Safety of Two Regimens of Adjustive Intravenous UFH PCI in High Risk Patients with UA/NSTEMI Initially Treated with Subcutaneous Fondaparinux and Referred for Early Coronary Angiography. Study Completed.
    47. STEM CELL. A Randomized, Double Blind, Multi Centric, Placebo Controlled, Single Dose, Phase I/II Study Assessing the Safety and Efficacy of Intravenous Ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cell in Patients with ST Elevated Acute MI (STEMI). Study Completed.
    48. RUBY 1Trial at The Heart Care Clinic /CIMS Ahmedabad (2010). A Randomized, Double Blind, Placebo Controlled, Multicentre and Parallel Group Study of the Safety, Tolerability, and Efficacy of YM150 in Combination with Standard Treatment in Secondary Prevention of Ischemic Vascular Events in Subjects with Acute Coronary Syndromes. Study Completed.
    49. AmarinTrial at The Heart Care Clinic/CIMS Ahmedabad (2010). A phase 3, Multi centre, Placebo Controlled, Randomized, Double Blind, 12 Week Study with an Open Label Extension to Evaluate the Efficacy and Safety of AMR101 in Patients with Fasting Triglyceride Levels > 500 mg/dl and <2000 mg/dl. Study Completed.
    50. AppraiseTrial at The Heart Care Clinic/CIMS Ahmedabad (2010). A Phase III, Randomized, Double Blind, Evaluation of the Safety and Efficacy of Apixaban in Subjects with a Recent Acute Coronary Syndrome. Study Completed.
    51. SAS HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2008). South Asian Systolic Heart Failure Registry. Study Completed.
    52. TRAC HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2009). TRAC HF: Ambulatory Monitoring Using External Physiological Sensors in Heart Failure Patients. Study Completed.
    53. DOT HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2009). DOT-HF- Diagnostic Outcome Trial in Heart Failure. Study Completed.
    54. T BEST D Trial at The Heart Care Clinic/CIMS Ahmedabad (2009). T-BEST-D: Temporary Bronchial Epicardial Stimulation – Defibrillation Clinical Study Version dated: June 28, 2009. Study Completed.
    55. ALECARDIO Trial at The Heart Care Clinic/CIMS Ahmedabad (2010). A phase 3 Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study Cardiovascular Outcome Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients with a Recent Acute Coronary Syndrome ( ACS) Event and Type 2 Diabètes Mellites (T2D). Study Completed.
    56. TIMI 52 Trial at The Heart Care Clinic / CIMS Ahmadabad (2010). A Phase 3 Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study of Darapladib versus Placebo in Subject Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events. Study Completed.
    57. SOLISTICE trial at CIMS Hospital Ahmadabad (2011). A Randomized ,Double-blind, Placebo-controlled Study to Evaluate the Safety of 12 Weeks of Dosing with GW856553 and its Effects on Inflammatory Markers, Infract Size, and Cardiac Function in Subjects with Myocardial Infarction without ST Segment Elevation. Study Completed.
    58. CANVAS study at CIMS Hospital Ahmadabad (2011). A Randomized. Double-blind, Parallel, Placebo-Controlled, Multicenter Study of the Effects of JNJ-28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus. The CANVAS Trial (Canaagliflozin cardioVascular Assessment Study). Study Completed.
    59. ATTAIN at CIMS Hospital Ahmadabad (2011). A Prospective, Non-randomized, Multi-center, Post-market, Global Clinical Trial to Assess Left-heart Lead Implant and Complication Rate Using the Medtronic Attain Family of Left-heart Leads and Delivery Catheters. Study Completed.
    60. TIMI 53 at CIMS Hospital Ahmadabad (2011). A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Sexagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patient with Type 2 Diabetes. Study Completed.
    61. OPTIMIND at CIMS Hospital Ahmadabad (2011). Clinical Outcome of Pacemaker Patients According to Pacing Modality and Primary Indications. Study Completed.
    62. SST at CIMS Hospital Ahmadabad (2011). The Pain Free SST (Smart Shock Technology) Clinical Study. Study Completed.
    63. VISTA 16 study at CIMS Hospital Ahmedabad (2011). Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndrome (ACS). VISTA-16: Vascular Inflammation Suppression to Treat Acute coronary syndrome for 16. Study Completed.
    64. TAO study at CIMS Hospital Ahmedabad (2011). Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban with Unfractionated Heparin + Eptifibatide, in Patients with Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy”. Study Completed.
    65. APOLLO study at CIMS Hospital Ahmedabad (2011). A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People Aliskiren Prevention of Later Life Outcomes (APOLLO). Study Completed.
    66. DELIVER study at CIMS Hospital Ahmedabad (2011).Deliverability of Resolute Integrity Stent In all- Comer Vessels and Cross over Stenting”. Study Completed.
    67. EPICOR ASIA study at CIMS Hospital Ahmedabad (2011). Long term follow up of antithrombotic management patterns In Acute coronary Syndrome patients in Asia. Study Completed.
    68. REMOTE-EVIA study at CIMS Hospital Ahmedabad (2011). Registry for Pacemaker Offering Therapy Enhancement- EVIA. Study Completed.
    69. ABSORB Extend (2011) A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the treatment of Subjects with de novo Native Coronary Artery Lesions. Study Completed.
    70. IHRS study at CIMS Hospital Ahmedabad (2011). Indian Heart Rhythm Society (IHRS) Registry of Atrial Fibrillation: Patient Characteristics and Clinical Management Practices. Study Completed.
    71. SureScan Pacing System Post-Approval Study at CIMS Hospital, Ahmedabad (2012). Study Completed.
    72. BISO-CAD (2012). A study to investigate the association between resting heart rate (HR) and prognosis of patients with Coronary Artery Disease (CAD) treated with bisoprolol. Study Completed.
    73. IMPROVE-Brady study at CIMS Hospital, Ahmedabad (2012). Study Completed.
    74. Medtronic Symplicity (2013) HTN-INDIA (CIP: 10054637DOC): Single-arm Study of Symplicity™ Renal Denervation System in Patients with Uncontrolled Hypertension in India – HTN-India. Study Completed.
    75. Panorama 2 Registry at CIMS Hospital, Ahmedabad (2012). Medtronic CRDM Implantable Cardiac Device Long Term Registry. Study Completed.
    76. CAD-PAD Registry at CIMS Hospital, Ahmedabad (2013). Coronary and Peripheral Artery Disease Registry. Study Completed.
    77. A Double-blind, Randomized, Placebo controlled, multicenter study assessing the impact of additional LDL-Cholesterol reduction on Major cardiovascular events when AMG 145 is used in combination with statin therapy in patients with clinically evident cardiovascular disease. Study Completed
    78. To Evaluate The Role Of Radiation Protection Technology (CardiotrapTM) In Improving Radiation Safety In Diagnostic And Interventional Percutaneous Cardiology Procedures. Investigator Initiated Study. Study Completed.
    79. Safety and Efficacy of Axiostat® hemostatic dressing on radial access after percutaneous procedure: A comparative open label study. Investigator Initiated Study. Study Completed.
    80. A Phase III, International, Multi-Centre, Randomized, Double-Blinded, Placebo-Controlled, Clinical Worsening study of UT-15C in Subjects with Pulmonary Arterial Hypertension Receiving Background oral Monotherapy (PH-310/11). Follow up Ongoing.
    81. An Open-Label Extension study of UT- 15C in subjects with Pulmonary Arterial Hypertension – A Long-Term Follow up to Protocol TDE-PH-304. Follow up Ongoing.
    82. A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus. Study Completed.
    83. A multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes. Study Completed.
    84. TWILIGHT-Ticagrelor with Aspirin or alone in high risk patients after coronary intervention. Study Completed.
    85. REDUAL-PCI at CIMS Hospital, Ahmedabad (2014). A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg bid.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting (RE-DUAL PCI). Study Completed.
    86. Asian HF Registry at CIMS Hospital Ahmedabad (2012) Asian Sudden Cardiac Death in Heart Failure. Follow up Ongoing
    87. PRISM at CIMS Hospital, Ahmedabad (2012). A Prospective Multi-Centre Registry to Investigate Safety and Effectiveness of M’Sure-S (Sirolimus Eluting Coronary Stent). Follow up Ongoing
    88. E Resolute Asia at CIMS Hospital, Ahmedabad (2010). Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Patient Population with Long Lesion(s) and/or Dual Vessels in Asia; Prospective, Multi-center, Non-randomized Study. Study Completed.
    89. INSPIRE-ELR at CIMS Hospital, Ahmedabad (2013). – Identifying High riSk Patients Post Myocardial Infarction with Reduced Left Ventricular Function using External Loop Recorders. Follow up Ongoing
    90. Improve SCA at CIMS Hospital, Ahmedabad (2014). For Improve Sudden Cardiac Arrest study. Study Completed.
    91. REPORT HF at CIMS Hospital, Ahmedabad (2014).International Registry to assess medical Practice with longitudinal observation for Treatment of Heart Failure. Study Completed.
    92. LUX- Head & Neck 2: A randomized, double blind, placebo- controlled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa or IVb loco-regionally advanced head and neck squamous cell carcinoma. Study Completed.
    93. LUX- Head & Neck 2: A randomized, double blind, placebo- controlled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa or IVb loco-regionally advanced head and neck squamous cell carcinoma. Study Completed.
    94. A 52-week treatment, multi-center, randomized, double blind, double dummy, parallel-group, active controlled study to compare the effect of QVA149 (indacaterol maleate/ glycopyrronium bromide) with salmeterol/fluticasone on the rate of exacerbations in subjects with moderate to very severe COPD” Study Number: Study Completed.
    95. A randomised, double-blind, active-controlled parallel group study to evaluate the effect of 52 weeks of once daily treatment of orally inhaled tiotropium + olodaterol fixed dose combination compared with tiotropium on Chronic Obstructive Pulmonary Disease (COPD) exacerbation in patients with severe to very severe COPD. DYNAGITO, Study Completed
    96. A 24-week, double-blind, randomized, parallel group study evaluating the efficacy and safety of oral nintedanib co-administered with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF) and advanced lung function impairment. . Study Completed.
    97. A 52-week, multicenter, randomized, double-blind, placebo controlled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma. . Study Completed.
    98. MORE CRT: MOre REsponse on Cardiac Resynchronization Therapy (CRT) with Multipoint Pacing (MPP). Recruitment Ongoing.
    99. ADVANCE CRT :  ADVANCE CRT REGISTRY. Study Completed.
    100. PFIZER CANCER : A Phase 3, Multicenter, Multinational, Randomized, Open-Label, Parallel-Arm Study Of Avelumab* (Msb0010718c) Plus Best Supportive Care Versus Best Supportive Care Alone As A Maintenance Treatment In Patients With Locally Advanced Or Metastatic Urothelial Cancer Whose Disease Did Not Progress After Completion Of First-Line Platinum-Containing Chemotherapy. Recruitment Ongoing
    101. BIVAFLO Registy (2006). To evaluate the Efficacy and Safety of BIVAFLO® as an Adjunctive Therapy During PCI in Moderate-high Risk ACS Patients with Provisional GP IIb/IIIa Inhibitors Use. (Completed)
    102. 100.CORREL + C Trial (2006). The COREL C Registry: A Multicentre Post Marketing Surveillance for Clinical and Angiographic Evaluation of Corel C Stent. (Completed)
    103. 101.POLYCAP Trial at The Heart Care Clinic/CIMS Ahmedabad (2007). A Randomized Double blind controlled trial of the efficacy And safety of POLYCAP Vs its components in subjects With at least one additional cardiovascular risk factor. (Completed)
    104. 102.ACUNOVA Trial (2006-2007). A phase III, open label, multi-centric, parallel group, Randomized study to evaluate the safety and efficacy of Abciximab in Indian patients scheduled for Percutaneuos Coronary Intervention. (Completed)
    105. ZYHI Trial at The Heart Care Clinic Ahmedabad (2007) Study Completed.
    106. 104.“The Dyslipidemia REMAINS Study” – A multicenter, prospective, observational study of lipid profiles and treatment patterns at presentation and after 12 weeks of statin therapy among Indian adults presenting with first coronary event, ongoing at CIMS Hospital Ahmedabad (2012). Study Completed
    107. 105.HF-Registry at CIMS Hospital, Ahmedabad (2012). A prospective, open label, multi-centric, observational registry for heart failure patients across India. Study Completed
    108. 106.“The International Polycap Study 3” (TIPS 3) at CIMS Hospital, Ahmedabad (2012) – A randomized double-blind placebo-controlled trial for the evaluation of a polycap, low dose aspirin and vitamin D supplementation in primary prevention. Follow up Ongoing.
    109. 107.BioMime Morph at CIMS Hospital, Ahmedabad (2016). A prospective, single-arm, multi-centre, observational, real world, post-marketing surveillance to evaluate safety and performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for very long coronary lesions. Recruitment Ongoing
    110. 108.TREASURE at CIMS Hospital, Ahmedabad (2015).A non-inTeRventional prospEctive observationAl Study to understand the usage pattern of Ticagrelor in Indian patients with acute coronaRy syndromE (TREASURE). Study Completed
    111. 109.A Prospective, Randomized, Multi-Center Study to Compare the safety, Tolerability and Efficacy of Bevacizumab (Zydus Cadila) with Bevacizumab (Avastin ®) in Non-Small Cell Lung Cancer (NSCLC). Completed
    112. 110.BIO-REPOSITORY – Collection of tumor tissue, serum sample and associated data from patients of various malignancies. Study Completed
    113. 111.PAREXEL COPD : 24-week Treatment, Randomised, Parallel-group, Double blinded, Double-Dummy, Multicenter Study to Assess the Efficacy and Safety of Aclidinium bromide/Formoterol fumarate compared with Individual Components and Placebo and Aclidinium bromide compared with Placebo when Administered to Patients with Stable Chronic Obstructive Pulmonary Disease [AVANT study]. Study Completed.
    114. 112.Asthma Protocol Title: A multi-center, randomized, 12-week treatment, double blind study to assess the efficacy and safety of QMF149 (150/80 microgram) compared with MF Twisthaler® (200 microgram) in adult and adolescent patients with asthma. Study Completed.
    115. 113.Bevacizumab: Protocol Title: An Open Label, Single Arm, Multicentric, Phase IV study to evaluate the safety and efficacy of Bevacizumab of Intas Pharmaceuticals Limited in approved indications. Study Completed.
    116. 114.Apixaban: Protocol Title: A phase iv, open label, multi-center study for safety evaluation of Apixaban in Indian participants undergoing elective total knee replacement or total hip replacement surgery. Study Completed.
    117. 115.Dapa HF: Protocol Title: Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic Heart Failure with Reduced Ejection Fraction :Follow up Ongoing.
    118. 116.Asia MRI: A post-market clinical evaluation of St. Jude MedicalTM  MR Conditional ICD System on patient undergoing Magnetic Resonance Imaging : Recruitment Ongoing.
    119. 117.OBTURATM VCD-PMS: A Prospective, Single-Blind, Multi-Center, Randomized, Post Marketing Clinical Study Comparing OBTURATM vascular closure device versus manual compression to evaluate safety and performance in patients who have undergone femoral artery puncture procedure: Recruitment Ongoing.
    120. 118.Paradise MI:  A multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high risk patients following an acute myocardial infarction: Recruitment Ongoing.
    121. 119.MOZEC – PK/PD : A prospective,  multi-center,  real world, post  marketing  surveillance  (PMS)  to  evaluate  safety  and performance  of  the  MOZEC  Sirolimus  Eluting  PTCA Balloon  Dilatation  Catheter for  In-Stent  Restenosis (ISR)  or  de novo  coronary  arteries in daily clinical practice.: Recruitment Ongoing.
    122. 120.PARALLEX :  “A 24-week, randomized, double-blind, multi-center, parallel group, active controlled study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction”. Follow up Ongoing.
    123. 121.SELECT : Semaglutide effects on cardiovascular outcomes in people with overweight or obesity: Recruitment Ongoing
    124. 122.MyVal-1: A prospective, multicentric, single arm, open label study of MyValTM Transcatheter Aortic Valve Replacement System in the treatment of severe symptomatic native aortic valve stenosis”.: Recruitment Ongoing
    125. 123.Peadiatric HF (2019): “Multicenter, open-label, study to evaluate safety, tolerability, pharmacokinetics and, pharmacodynamics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared with enalapril in pediatric patients from1 month to < 18 years of age with heart failure due to systemic left ventricle systolic dysfunction”: Recruitment Ongoing
    126. 124.COR10649 (2019): Effectiveness and Safety of Optical Coherence Tomography-Guided PCI in Indian Patients with Complex Lesions – A Multicenter, Prospective Registry: Recruitment Ongoing
    127. 125.Glenmark – OA : A Phase 2 dose- range finding 12-week, double-blind, randomized, parallel group study to evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritis pain.: Recruitment Ongoing
    128. 126.SLE: 14V-MC-JAIA: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in patient with Systemic Lupus Erythematosus.: Recruitment Ongoing
    129. 127.CQAW039A2315: A Two treatment epoch, randomized placebo-controlled, multi-centered parallel group study to assess the safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma: Follow up Ongoing
    130. 128.CQAWO39A2317: A 12-week, multicenter, randomized, double-blind, placebo controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma.: Study Completed
    131. 129.Glenmark COPD: A randomized, double-blind, clinical trial to assess the efficacy and safety of fixed dose combination Dry Powder Inhaler of Glycopyrronium 12.5 µg/Formoterol Fumarate 12 µg/Fluticasone Propionate 250 µg in comparison with fixed dose dry powder inhaler Glycopyrronium 50 µg co-administered with fixed dose dry powder inhaler combination of Formoterol Fumarate 12 µg/Fluticasone Propionate 250 µg in patients with chronic obstructive pulmonary disease: Recruitment Ongoing
    132. 130.My-dol-4001: An Open-label, Multicenter, Prospective, Phase-IV, Interventional Study to Evaluate the Safety, Tolerability & Efficacy of Dolutegravir (50 mg once daily) in Treatment Naïve Adult Indian Subjects Infected with HIV-1, Eligible to Receive Dolutegravir with Tenofovir & Lamivudine.: Recruitment Ongoing

Ethics Committee of Care Institute of Medical Sciences (EC CIMS) is the first Ethics Committee in India accredited by National Accreditation Board for Hospitals and Healthcare Providers (NABH).

 

History of EC CIMS


  • 2006 – Established Ethics Committee of Heart Care Clinic
  • 2009 – Registration of EC with IROG IRB registration No. IROG 0006900
  • 2010 – EC of Heart Care Clinic re-established as EC of Care Institute of Medical Sciences
  • 2013 – EC CIMS registered by Central Drugs Standard Control Organization(CDSCO),No. ECR/206/Inst/GJ/2013
  • 2016-17 – Renewal of EC CIMS till 2019, No. ECR/206/Inst/GJ/2013/RR-16
  • 2017 – First EC in country to get NABH registration (5/8/2017-5/8/2020)

Scope of EC CIMS


Review and approve clinical trials/studies (drugs and devices) both observational, academic, Investigator’s Initiated, and experimental studies from Phase I to Phase IV, Bioavailability / Bio-equivalence (BA/BE) studies, Clinical Registry and Others (e.g. Bio-Banks, tissue research, nutraceuticals and food products )

Constitution of EC CIMS


The EC CIMS is multidisciplinary and multi-sectored in composition including relevant scientific expertise, balanced age and gender distribution, legal expert and / or a social scientist lay person to safeguard the interests and welfare of all sections of community / society.

  • The EC CIMS is constituted in accordance with the Schedule Y of the Drugs and Cosmetics Act, CDSCO-GCP Guidelines for Clinical Trials on Pharmaceutical Products (2001), ICMR Ethical Guidelines for Biomedical research on Human Subjects (2006) and in accordance with the value and principles of the communities they serve.

Responsibilities


EC CIMS members are dedicated to their roles and responsibilities include:

  • Safeguarding the rights, safety and well-being of all trial subjects.
  • Actively participate in the EC Meeting.
  • Review, discuss and approve research Proposals submitted for evaluation.
  • Monitor Serious Adverse Event (SAE) reports and recommend appropriate action(s)
  • Review the progress reports and monitor ongoing studies as appropriate.
  • Evaluate final reports and outcomes.
  • Maintain confidentiality of the documents and deliberations of EC meetings.

Flow chart of EC Work


 

 

 

 

 

Number of Protocols Reviewed and Approved yearly


CIMS is keen to support the continued advancement of medical practices through clinical research. Kindly contact EC CIMS for being reviewed and approved for all clinical trials from Phase I to Phase IV as well as Bioavailability/Bio-equivalence (BA/BE) studies.

Ethics Equates to Esteem of Existence


CIMS Ethics Committee invites self-nominations for being a committee member.

Nominations are open to following categories:

    • 1.Clinicians: A qualified and experienced registered doctor with post graduate qualifications with adequate experience in their respective fields and aware of their role and responsibilities as Ethics committee members. Knowledge of Good clinical Practices would be an advantage. Nominations are open to doctors attached to CIMS hospital also.
    • 2. Legal Expert: A legal person can be a retired expert in law (judge) or medico-legal expert
    • 3. Social Scientist/ Representative of Non-Governmental Voluntary Agency/ Philosopher, Ethicist or Theologian: A graduate with specialisation in social ethics, intercultural ethics, and the ethics of gender and vulnerable population
    • 4. Lay Person from the community: This includes individuals with expertise in ethics, animal welfare, social sciences as well as members of the local community. Ideally, individuals should have no vested interest in the research and be independent of the particular science faculty or establishment.
    • 5. Member Secretary: The secretary shall be from CIMS and will be in charge of the secretariat of the EC and responsible for reporting to the chairperson on all matters related to the EC .Knowledge of English language and computer skills is essential.

Kindly forward your nomination to ethicscommittee@cims.org

CIMS Medical Team is self-committed and self-evolving towards continuing medical education.

Dedicated to educate oneself and be a part of academics, they keenly contribute to medical publications and be a part of global medical library.

  1. Uri Elkayam, Keyur Parikh, Shahbudin Rahimtoola. Absence of effect of Diltiazem on Digoxin Serum Concentration and Renal clearance in Patients with Cardiac Disease. JACC, 1985 Vo.2, Part 2 Page 419(Abstract)
  2. Uri Elkayam, Keyur Parikh, Behrooz Torkan, Laura Weber, Jorden Cohen, Shahbudin Rahimtoola. Effect of Diltiazem on Renal Clearance and Serum Concentration of Digoxin in Patients with Cardiac Disease. Am J Cardiol 1985;55(11):1393-5.
  3. Keyur Parikh, Peter Mahrer , Amar Kapoor, Kaiser Hospital, Los Angeles. Subsets of Left Main Coronary Artery Disease: Clinical and Impact on Artery Disease: Clinical and Impact on Survival Correlating with Angiographic  Data . 1985-1987.
  4. C. Chag Dissertation: “Clinical Profile of Right Ventricular Infraction” submitted to Saurashtra University for MD Examination November 1986.
  5. Yajnik V.H., Vatsraj D.J., Jobanputra R.H.,Chag M.C., Vacchani M.P.: A Comparative Evaluation of Two Antidiarrhoeal Agents in Acute Diarrhoea in Adults. Guj. Medical J 1986, 10:108.
  6. Keyur Parikh, Peter Mahrer, Kaiser Hospital, Los Angeles. Clinical Profiles of Atrial Myxomas. Cardiovascular Review And Reports (1987)
  7. Yajnik V.H., Chag M.C., Glimpses of Progress in Management of Essential Hypertension, in “Current Concepts in Cardiology,” in Kothari U.R., Oza Y.K., (eds) Jamnagar, Association of physicians of Gujarat, 1987, P.46.
  8. Vatsraj D.J., Chag M.C., Jadhav U.M. : Refractory Heart Failure, in “Current Concepts in Cardiology” in Kothari U.R., Oza Y.K.,(eds.) jamnagar, Association of Physicians of Gujarat, 1987, P.124.
  9. Chag M.C., Kulkarni P.S.: Clinical Profile of Right Ventricular Infarction: Presented as Paper in 8th Annual Conference of Association of physicians of Gujarat, Jamnagar, 1987.
  10. Mehta A.B., Munsi S.C., Chag M.C., HendaS : Percutaneous Transluminal Coronary Angioplasty in Multivessel Coronary Artery Disease. Indian Heart J 1989; 41:1.
  11. Chag M.C., Sinha N.S., Goel P.K.: Dipyridamole Echocardiography for Severity and location of Coronary Artery Disease. Indian heart J 1992; 44:300.
  12. Chag M.C., Sinha N.S., Radhakrishnan S., Bidwai P.S.: Non-Specific Aortoarteritis: Clinical, Immunological and Angiographic profile and Follow-up. Indian Heart J 1992; 44:295.
  13. Shah S, Chag M.C., Mantri R.R., Lal M., Bajaj R., Ghosh P.K. : Tricuspid Annuloplasty: obajective Analysis of its Efficacy. Scientific Abstract: Annual Conference of Indian Association of cardiovascular and Thoracic Surgeons: Feb. 1992, Calcutta, India, P.50.
  14. Rastogi N., Chag M.C., Ayyagari S: Myocardial Ischemia after 5-Fluorouracil chemotherapy. International J Cardiol 1993; 42:285-287.
  15. Shrivastava S, Chag M.C.: Balloon Mitral Valvuloplasty for Rheumatic Mitral Stenosis, in “Recent Advances in Cardiology, In Trehan None, Anil Kumar (eds.) New Delhi, Escort Heart Institute, 1993.
  16. Agarwal A, Misra R,Chag M.C., Sinha N.: Elevated AnticardiolipinAntibiodies in Takayasu’s Arteritis. Presented a Paper in Annual Conference of Rheumatology, New Delhi, 1993.
  17. Agarwal A, Sinha S,Chag M.C., Naik S: HLA Antigens in Aortoarteritis: Presented as Paper in National Symposium on HLA, New Delhi, 1993.
  18. Agarwal A, Sinha S, Chag M.C., Naik S: Takayasu’s Arteritis: Roal of mycobacterium Tuberculosis in its Pathogenesis: Presented as paper in Annual Conference Rheumatology, New Delhi, 1993.
  19. C. Kaji, G.R. Bhagat.  Shah U.G.  A study of 66 cases of mediastinal mass. Indian Journal of Internal Medicine,1993,No-8-10,248-253.
  20. Misra R, Agarwal A, Chag M.C., Sinha N., Shrivastava S. : Elevated Anticardiolipin Antibodies in Takayasu’sArteritis:Lancet 1994; 343 : 1644-1645.
  21. Chag M.C., Dani S.I., Patel T.M., Thakore S.B., Rawal J.R., Patel TK: Situs abnormality and Cardiac Malpositions. Indian Heart Pulmonary  Stenosis, Study of 42 cases: Indian Heart J 1994; 46;220.
  22. Dani S.I., Patel T.M.,Chag M.C., Rawal J.R., Thakore S.B., Shah U.G., Patel T.K. : Balloon Pulmonary Valvuloplasty in Adult Pulmonary Stenosis, Study of 42 cases : Indian Heart J. 1994; 46:220.
  23. Chandra Y.V., Chag M.C., Kapoor L., Mittal P.K. Mahant T.S., Srivastava A.K., Ghose P.K., Srivastava S.: Fate of Tricuspid Regurgitation in Mitral valve Disease after surgery with/without Tricuspid valve Annuloolasty. Indian Heart J 1994; 46:259.
  24. Dani S.I., Patel T.M., Chag M.C., Patel T.K.: Modified Inoue Technique for BMV in Difficult situations: Indian Heart J 1994; 46:259.
  25. Patel T.M., Dani S.I., Chag M.C., Patel T.K.: Coronary Angioplasty in Chronic total occlusions. Indian Heart Journal 1994; 46:250.
  26. Lal M., Mantri R.R., Chag M.C., Ganjoo A.K., Srivastav A.K., Mahant T.S.,: Echocardiographic assessment and outcome of closed and open heart surgery in patients with rheumatic tricuspid valve disease: Tropical Cardiology 1994; 20 (78): 54-60.
  27. Patel T.M., Dani S.I., Chag M.C., Thakore S.B., Rawal J.R., Shah S.C., Patel T.K., : Balloon Peripheral Angioplasty in Iliofemoral Disease. Indian Heart J 1994; 46:252.
  28. Mishra R., Prasad N., Agarwal A., Chag M.C., Sinha N., Shrivastava S.,: Raised Anticardiolipin Antibody in Takayasu’s Arteritis: Indian Heart J 1994; 46:253.
  29. Dani S.I., Patel T.M.,Chag M.C., Rawal J.R., Thakore S.B., Shah U.G., Patel T.K. : Balloon Pulmonary Valvuloplasty in Adult Pulmonary Stenosis, Study of 42 cases : Indian Heart J. 1994; 46:220.
  30. Patel T.M., Dani S.I., Chag M.C., Shah U.G., Shah S.C., Patel T.K.: Troubleshooting of inoue balloon Tear during Percutaneous Balloon Mitral Valvuloplasty: J CathetcardiovascDiagn (in Press).
  31. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Thomas V M, Patel T K : How to minimise radiation to foetus during balloon mitral valvuloplasty in pregnant women. Ind Heart J : 47: 6 : 80; 1995(abstract).
  32. Dani S.I., Patel T.M., Chag M.C., Thakore S.B., Patel T.K., Difficult Mitral Valvuloplasty: An “over the wire” modification of Inoue Technique: J Invasive Cardiology 1995; 7:148-151.
  33. Patel T.M., Dani S.I., Chag M.C., Shah U.G., Shah S.C., Patel T.K.: Troubleshooting of inoue balloon Tear during Percutaneous Balloon Mitral Valvuloplasty: J CathetcardiovascDiagn (in Press).
  34. Chag M C, Dani S I, Patel T M, Shah S C, Shah U G, Thomas V M, Patel T K : Balloon angioplasty for native coarctation of aorta beyond infancy. Ind Heart J :  47: 6 : 164; 1995(abstract).
  35. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Thakore S B, Rawal J R, Patel T K : Technical challenges in PTCA with reused hardware. Ind Heart J : 47: 6 : 219; 1995(abstract).
  36. Patel T M, Dani S I, Rawal J R, Shah U G, Thomas V M, Baxi H, Patel T K : Balloon mitral and aortic valvuloplasty in mirror-image dextrocardia. Ind Heart J : 48: 5 : 240; 1996(abstract).
  37. Dani S I, Patel T M, Rawal J R, Shah S C, Shah U G, Jain S, Patel T K : Elective primary stenting for complex coronary lesions : clinical and angiographic follow up. Ind Heart J : 48: 5 : 164; 1996(abstract).
  38. Patel T M, Dani S I, Rawal J R, Shah U G, Thomas V M, Baxi H, Patel T K : Balloon mitral and aortic valvuloplasty in mirror-image dextrocardia. Ind Heart J : 48: 5 : 240; 1996(abstract).
  39. Patel T M, Dani S I, Shah S C, Shah U G, Patel T K : Balloon pulmonary valvuloplasty using the Inoue catheter : A novel ‘free-float’ Inoue technique. J Invas Cardiol, Oct.1996.
  40. Patel T M, Dani S I, Chag M C, Thakore S B, Shah S C, Shah U G, Patel T K : Balloon mitral and aortic valvuloplasty in mirror image dextrocardia. J Invas Cardiol 8 : 164-168, 1996.
  41. Balloon Mitral Valvuloplasty in Calcific Mitral Stenosis : Immediate and Mid Term Results: Bhupesh Shah, Sameer Dani, Jayesh Rawal, Urmil Shah, Vipin Thomas, Sharad Jain. Institute of  Cardiology and Research Centre, Ahmedabad. Indian Heart J 1997 ; 49 : 629. IHJ, Nov-Dec. 1997.
  42. Multitrack System for Balloon Mitral Valvuloplasty : Initial Results : Jayesh Rawal, Sameer Dani, Bhupesh Shah, Urmil Shah, Institute of Cardiology and Research Centre,Ahmedabad.Indian Heart J 1997 ; 49 : 630. IHJ, Nov-Dec. 1997.
  43. Concurrent Multivalvular Balloon Dilatation : Acute Results and Short Term Follow-up : Urmil Shah, Sameer Dani, Bhupesh Shah, Jayesh Rawal, Sharad Jain, Jayesh Prajapati, Anish Chandarana, Hasit Joshi, Institute of Cardiology and Research Centre, Ahmedabad.Indian Heart J 1997 ; 49 : 633. IHJ, Nov-Dec. 1997.
  44. Pura Vario – A Poor Man’s Stent : Six Months Clinical and Angiographic Follow – up : DR Solanki, SI Dani, BR Shah, UG Shah, SR Jain, J Prajapati, A Chandarana. UN Mehta Institute of Cardiology and Research Centre, Civil Hospital, Ahmedabad. Indian Heart J 1998 ; 50 : 639. IHJ, Nov-Dec. 1998.
  45. Combination of Plain PTCA with Stenting in Coronary Artery Disease : Immediate and Intermediate – Term Outcome. SI Dani, BR Shah, UG Shah, SR Jain, H Baxi, A. Chandarana UN Mehta Institute Of Cardiology  and Reserch center , Civil Hospital, Ahmedabad . Indian Heart Journal 1998; 50 : 663. IHJ , Nov-Dec. 1998.
  46. Satya Gupta Affect of plasmodium falciparum and plasmodium vivax infection on renal functions. SDMH Jour (ISSN 0970-0390) 1998; 22:53-58
  47. Non-Surgical Mitral Commissurotomy Using A New Metallic Dilator : SI Dani, SR Jain, BR Shah, UG Shah, J Prajapati, DR Solanki, H Joshi, UN Mehta Institute of Cardiology and Research Centre, Civil Hospital, Ahmedabad.Indian Heart J 1998 ; 50 : 645. IHJ, Nov-Dec. 1998.
  48. Retrieval Of Foreign Material From Vascular System: An Appraisal of arious retrival devices:SI Dani, DR Solanki, BR Shah , UG Shah , SR Jain, H baxi ,H. Joshi   UN Mehta Institute  of  Cardiology and Reserch Center,Civil Hospital Ahmedabad .Indian Heart Journal 1998;  50 : 675. IHJ , Nov – Dec  1998
  49. Ballloon Dilatation of Coarctation  of Aorta  in  adults: Immediate and   Folllow Up  ;SI Dani , BR Shah,UG Shah. DR Solanki, J Prajapati , A Chandarana  UN Mehta   Institute  of Cardiology and Reserch Center.Ahmedabad. Indian Heart Journal 1998 ;  50 : 691.  IHJ Nov – Dec 1998
  50. Left Main Coronary  Artery   disease   in Gujarati Population., SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  51. Immediate and Short Term Outcome of Patient Undergoing Plain  PTCA  SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  52. Stent Implantation in Coronary Artery Disease: Acute and Mid Term Results SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  53. Pulmonary Stenosis : Long term Results of Balloon Dilation SI Dani , Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  54. Balloon Dilatation of Coarctation of AORTA: Immediate results and Intermediate Follow Up SI Dani , Jayesh Rawal Bhupesh Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON  3-4 jan    1998;   Ahmedabad, Gujarat.
  55. Permanent Pacemaker Implatation In  Gujarat: A Single Center Experience SI Dani, Jayesh Rawal Bhupesh  Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 Jan 1998;   Ahmedabad, Gujarat
  56. Intracoronary “Saint Come” Stents : Short and Mid-Term Follow-up Results : BR Shah, SI Dani, UG Shah, SR Jain, DR Solanki, H Baxi, A Chandarana. Department of Cardiology, UN Mehta Institute of Cardiology and Research Centre, Civil Hospital,Ahmedabad.Indian Heart J 1998 ; 50 : 639. IHJ, Nov-Dec. 1998
  57. Economical Consideration in  Percutaneous  Dilatation of Mitral  Valve  by Different Device and Hardware  JR Rawal , UG Shah,  JS Prajapati , BR Shah,  AH Chandarana , SI Dani   UN  Mehta Institute of Cardiology and  Research  Center ,  Civil Hospital  Indian Heart Journal 1999 ; 51: 723. IHJ  Dec 1999
  58. K H Parikh et al. Use of Abciximab (Reopro): In High Risk Coronary Artery Disease Patients During Angioplasty and Stents. Gujarat Medical Journal 1999;56:1
  59. Comparision of Intravenous nicorandil  with Intravenous  Nitroglycerine in Patients with Unstable Angina .UG Shah , S Jain , P Jethavani , S Thanvi , BR shah,  SI Dani  UN Mehta  Institute of Cardiology  and Reserch Center ,civil Hospital Ahmedabad.  Indian Heart Journal 1999 ; 51 : 704 . IHJ  Dec  1999
  60. Five Year Follow up after Inoue Balloon Mitral Valvuloplasty in Juveniles . JR Rawal, JS Prajapati, UG Shah , S Jain, SI Dani    UN  Mehta Institute  of Cardiology and Research Center,  Civil Hospital, Ahmedabad. Indian Heart Journal 1999; 51 732. IHJ Dec  1999
  61. Agarwal A, Chag M.C., Shinha N., Naik S.:Takayasu’s Arteritis: Roal of Mycobacterium tuberculosis and its 65 KD heart shock protein in pathogenesis: Annals of Rheumatic Diseases (In Press).
  62. K H Parikh. HCPR Guidelines for Heart Failure Therapeutics. Indian Heart J 2000; 52(6):668-830.
  63. K H Parikh (CSI). Ischemic Heart Disease Endothelial Dysfunction. Indian Heart J 2000; 52(6):668-830.
  64. Keyur Parikh (CSI). Gujarat Earthquake – A Cardiologist’s Perspective. Indian Heart J 2000; 52(6):668-830.
  65. Dhiren Shah – Unusual presentation of ASD device with large la clot on it—Poster presentation in IACTS 2001
  66. Chag M.C., Patel T.M., Dani S.I., Thakore S.B., Rawal J.R., Jain S.K., Patel T.K.,: A Left Femoral Vain Approach For Percutaneous Tranvenous Mitral Commissurotomy: J Invasive Cardiology (In Press).
  67. Parikh K.H., Chag M.C, Shah U.G, Baxi H.A., Chandarana A.H., Naik A.M, Goyal R.K., Shah K.J. Acute results and Intermediate term follow up of PCI with Cardioprotection by Balloon Occlusion Distal Protection Device. Indian Heart J. J-233, 2002; 54: 561-568.
  68. Shah K.J., Chag M.C. Homocysteine- A risk marker for coronary artery disease. CMJ North Zone 2003: 9, No: 2: 23- 26.
  69. Shah H, Iyer S, Mehta K, Parikh K, Jain A, Goyal RK. Pharmaco-epidemology and Risk Factors of Hypertension in Western Gujarat (Abstract). Indian Journal of Pharmacology 2003; 35(4);277.
  70. Satya Gupta Heart failure: What proportion of patients satisfies the Electrocardiographic criteria for cardiac resynchronization therapy? Indian Heart J 2003; 55:619-623.
  71. Satya Gupta Utility of N-Terminal Pro BNP in the diagnosis of heart failure. Indian Heart J 2003; 55:35-39.
  72. Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., NaikA.M.,Shah K.J., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using Boluses of IC Adenosine and Sodium Nitroprusside. Suppl to JACC, March 19, 2003; 41 (6), Suppl A: 1101- 201
  73. Shah KJ, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Prevalence of Hyper–homocysteinemia in Western Indian Population with or Without Coronary Artery Disease Indian Journal of Cardiology 2003; 6:54-58.
  74. Shah K.J., Chag M.C., Parikh K.H., Goyal R.K. Homocysteine and Coronary Artery Disease (Review). Indian Pharmaceutical Sciences (submitted).
  75. Satya Gupta Mortality and morbidity due to acute ST segment elevation myocardial infarction in the current era. Indian Heart J 2004; 56:210-214.
  76. Satya Gupta Prevalence of coronary artery disease in patients with rheumatic heart disease. Indian Heart J 2004; 56:129-131.
  77. Satya Gupta Blood filled cysts of heart. Indian Heart J 2004; 56:174-175.
  78. Dhiren Shah – Comparison of Starr Edward Valve against other Mechanical valve in Indian scenario—Paper presentation in ISMICS conference 2003-04.,and also the dissertation topic
  79. Dr Dhiren Shah – VSD repair in hypertensive pulmonary artery pressure—dissertation topic
  80. Parikh KH, Shah HD, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Improvement In Mace By Sequential Administration Of Boluses Of Intracoronary Adenosine And Sodium Nitroprusside During Percutaneous Coronary Interventions. (Poster Presentation at Annual Congress) European Society of Cardiology, 2004, Munich, Germany.
  81. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  82. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Goyal RK. Beneficial effects of addition of fenofibrate to statins in acute coronary syndrome  patients undergoing Percutaneous Coronary Interventions. World Heart (Submitted)
  83. Parikh KH, Shah HD, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Shah JN, Goyal RK. Revascularization in Acute Myocardial Infarction Using Percusurge In Distal Protection (RAPID). World Heart J (Submitted)
  84. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004.
  85. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of combination of statins and fenofibrate with acute coronary syndrome undergoing Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004.
  86. Chag M.C., Shah H. D., Parikh K.H., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Increased Lipoprotein (a) as a strong risk factor for Coronary Artery Disease and the effect of Niacin amongst Indians. European Society of Cardiology (Submitted) 2004.
  87. Mehta K N, Parikh K H, Chag MC, Shah U G, Baxi H A, Chandarana A H, Naik A M, Goyal R K, Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study,2005.
  88. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal   RK,  Association of White Blood cell count with the Occurrence of slow/no reflow in acute  coronary Syndrome patients undergoing PCI.2005.
  89. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK, Efficacy of Percusurge Guardwire system in acute Myocardial patients undergoing Primary/rescue PCI.2005.
  90. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK. Association of White Blood cell count with the Occurrence of slow/no reflow in acute coronary Syndrome patients undergoing PCI. Poster presentation at Joint International Conference of ISHR and IACS, Jan 2005, Gujarat, India.
  91. Dhiren Shah – Pulsatile flow during cardiopulmonary bypass using intra-aortic balloon pump favors cardiac surgery outcome in pregnant woman, Poster presentation at IACTS 2005
  92. Dhiren Shah – Ventricular overlap- an alternative to heart transplantation: our early experience  -paper presentation in IACTS 2005, and JATS 2005
  93. Shah KJ, Iyer SS, Parikh KH, Goyal RK. Dual RAAS Blockade with ACE-I and ARB. Indian Journal of Cardiology
  94. Parikh KH, et al. Development of Group Practice in Cardiology, Financial Planning and Research and Development. CSI Book 2005.
  95. Dhiren Shah – An atypical presentation of Aneurysm of Sinus of Valsalva (ASV)—Poster Presentation at IACTS 2005
  96. Dhiren Shah – Surgical ventricular restoration (SVR)- a comprehensive surgical therapy for patients with congestive heart failure—Paper presentation in IACTS 2005 and  JATS 2005(Japanese association)
  97. Dhiren Shah – Effect of surgical ventricular restoration on functional status, left ventricular function and Mitral valve regurgitation in Indian patients – an immediate and intermediate term study—Paper presentation at IACTS 2005.
  98. Satya Gupta Recanalization of single functioning kidney (Case report). Indian Heart J 2005; 57:741-743
  99. Parikh KH, Shah HD, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Rozenman Y. Effect of Metaprolol XL on Diurnal variation impulmonary arterial pressure in Heart Failure patients using first-in-man implantable device responding to ultrasonic signals. Presented in Poster session at ACC Conference on March 14,2006. Atlanta.
  100. KH Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, AH Chandarana, A Hjalmarson, Y Rozenman. First In Man: Measurement of Diurnal Variation in Pulmonary Artery Systolic and Diastolic Pressure in Heart Failure Patients Using an Innovative Implantable Device Responding to Ultrasonic Signals. Eur Heart J (2006) 27(suppl 1) 291-565. Abstract Number: P2949.
  101. Parikh KH, Shah HP, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Rozenman Y. First in man: Papirus-monitoring Pulmonary artery Pressure by Implantable device Responsible to Ultrasonic signals. Oral Presentation at the Late Breaking Clinical Trials Session at the ACC-i2 summit, ACC Conference, March-12, 2006.
  102. KH Parikh, HA Shah, AH Chandarana, AM Naik, MC Chag, UG Shah, HA Baxi, JN Shah, A Medina, S Banai. First In Man: Multislice CT Angiography Visualization Of An Innovative First-in-man Coronary Sinus Reducer Stent In Patients With Refractory Angina. Presented at TCT- October 2006, Washington DC.
  103. Parikh KH, Shah HP, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y. First in Human Implanted Device in Pulmonary Artery Using Acoustic Telemetry Based on Non-Invasive Ultrasound Activation and Communication. J Am Coll Cardiol 2006;47;1B-56B. Abstract Number: 2926-71.
  104. Kanan Shah, Keyur Parikh, Milan Chag, Urmil Shah, Anish Chandarana, Hemang Baxi, Ajay Naik, Ramesh K. Goyal, Avigilance study of distal protection device used during Percutaneous coronary interventions. 2006
  105. KH Parikh, HA Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, MP Tanna, MC Chag, Initial Clinical experience with Bivalirudin as an anticoagulant during percutaneous coronary interventions in Asian Indian patients,2006
  106. KH Parikh, HA Shah, JN Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, RK Goyal, MC Chag, Prospective randomized study of PercuSurge in Acute Myocardial Infarction Patients undergoing Revascularization with a special Emphasis on Procedural Time: A Two Year Follow-up. 2006
  107. Chandarana AH, Shah JN, Shah HA, Shah UG, Baxi HA, Naik AM, Joshi M, Goyal RK, Parikh KH, Chag MC. High Prevalence Of Renal Artery Stenosis In Hypertensive Patients With Triple Vessel Coronary Artery Disease: Recommendation For Simultaneous Renal Arteriogram For Earlier Intervention.2006
  108. HA Shah, JN Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, AM Naik, KH Parikh, RK Goyal. Association between the White Blood Cell Count and Occurrence of Slow or No Reflow Phenomenon in Patients with Acute Coronary Syndromes in the coronary Interventional Era,2006
  109. HA Shah, MC Chag, MP Tanna, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, KH Parikh. Incidences and Clinical Characteristics of No Reflow after Percutaneous Coronary Interventions in High Risk Asian Indian Patients. 2006
  110. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Goyal RK. Effect of Statins in combination with fenofibrate on Plasma fibrinogen: A cardiovascular risk factor. Pharmacol Res (Submitted)
  111. HA Shah, MC Chag, MP Tanna, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, KH Parikh. Incidences and Clinical Characteristics of No Reflow after Percutaneous Coronary Interventions in High Risk Asian Indian Patients. 2006
  112. Parikh, AM Naik, HA Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, JN Shah, A Medina, S Banai, First In Man: Direct Comparison Of Conventional Coronary Sinus Angiography And CT Angiography For Visualization And Sizing Of Coronary Sinus,2006
  113. Parikh, HA. Shah, AM. Naik, HA. Baxi, MC. Chag, UG. Shah, A. Hjalmarson, Y. Rozenman, First in Man: non-invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry,2006
  114. KH Parikh, AM Naik, HA Shah, HA Baxi, MC Chag, UG Shah, AH Chandarana, Y Rozenman. First In Man Non-Invasive Monitoring of Pulmonary Artery Pressure from an Implantable Device Using Acoustic Telemetry: A One Year Follow-Up Data. Eur Heart J (2006) 27(suppl 1) 1-290. Abstract Number: P1363
  115. KH Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, AH Chandarana, A Hjalmarson, Y Rozenman. First In Man: Effect of Metoprolol CR/XL on Exercise Capacity and Subsequent Variation in Pulmonary Artery Pressure in Heart Failure Patients Using an Innovative Implant Involving Acoustic Telemetry. Eur Heart J (2006) 27(suppl 1) 827-985. Abstract Number: P5412.
  116. KH Parikh, HA Shah, AM Naik, HA Baxi, MC Chag, AH Chandarana, A Hjalmarson, Y Rozenman. First In Man: Measurement of Diurnal Variation in Pulmonary Artery Systolic and Diastolic Pressure in Heart Failure Patients Using an Innovative Implantable Device Responding to Ultrasonic Signals. Eur Heart J (2006) 27(suppl 1) 291-565. Abstract Number: P2949.
  117. Banai S, Keren G, Sievert H, Seth A, Ben Muvhar S, Naik AM, Medina A, Chandra P, Shah H, Parikh KH. First-in-man: Coronary Sinus Narrowing with a Reducer Stent- A Possible Alternative Percutaneous Treatment for Patients with Refractory Angina. J Am Coll Cardiol 2006;47;1B-56B. Abstract Number: 2909-121.
  118. HA Shah, RK Goyal, AM Naik, HA Baxi, MC Chag, A Hjalmarson, Y Rozenman, KH First In Man Study: Effect of Metoprolol CR/XL on Diurnal Variation in Pulmonary Artery Pressure Assessed Non-invasively Using an Innovative Implantable Device Responding to Ultrasonic Signals. Eur Heart J (2006) 27(suppl 1) 291-565. Abstract Number: P2158.
  119. Dr Dhiren Shah – TREATMENT OF CONGESTIVE HEART FAILURE (CHF) DUE TO POST MYOCARDIAL INFARCTION DILATATION USING DIFFERENT TECHNIQUES OF SURGICAL VENTRICULAR RESTORATION (SVR)—paper presentation at  IACTS 2006 Bangalore
  120. Keyur H. Parikh. Using the Remon Pressure Device: One Year Follow-up. Presented at Innovations in Cardiovascular Interventions (ICI), Israel, 2006.
  121. Parikh KH, Shah HA. A Year in Percutaneous Interventions. Published In Cardiology Update 2006.
  122. Parikh KH, Shah HD, et al. Stem Cell Therapy in ACS; Type, Timing and Promise. The Post-Graduate Medicine, 2006.
  123. Dr Dhiren Shah – EARLY RESULTS OF 12 CASES OF OVERLAPPING CARDIAC VOLUME REDUCTION (OLCVR) – GEOMETRIC & CLINICAL OUTCOMES—–oral paper presentation  at IACTS 2006.
  124. Hygriv B Rao, , K.Raghu, Vipul Kapoor, Sharada Kalavakolanu,Narasimhan Calambur,B. Somaraju. Tissue Doppler Imaging in Refractory Heart Failure- Implications for CRT. Heart Rhythm 2006; 3:1S, S 81
  125. Dr Dhiren Shah – Chordal cutting of AML for  Ischaemic  Mitral regurgitation  —-Case study of 3 cases—–Poster presentation  at IACTS 2006
  126. Should I send my Patient with severe LV dysfunction and Mitral regurgitation for surgery—–Presentation at 3C CON conference2006 at Ahemdabad
  127. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Iyer S, Goyal RK. Beneficial Effects of Addition of Fenofibrate to Statin Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Interventions. Exp Clin Cardiol 2007:12:91-6.
  128. Dr Dhiren Shah – Coronary artery disease and Heart failure —a dangerous intersection  —-lecture at 3C Con conference 2007
  129. Heart failure and Mitral regurgitation – authored an article in Cardiology Today march-April 2007 Vol.IX No.2
  130. Dr Dhiren Shah – Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction Volume 85, Number 2, February 2007ISSN 1205-7541
  131. Dr Dhiren Shah – Beneficial effect of endoventricular circular patch plasty in patients with left ventricular dysfunction and with left ventricular akinetic and dyskinetic apical segment—– Indian journal of cardiothoracic and vascular surgery  2007-23:16-24
  132. Dr Dhiren Shah – OUR EXPERIENCE OF VENTRICULOSEPTOPLASTY WITH LINEAR REPAIR IN CASES OF AKINETIC /DYSKINETIC ANTEROSEPTAL LEFT VENTRICULAR WALL IN ISCHAEMIC CARDIOMYOPATHY  – STUDY OF 75 CASES- Oral paper  presentation in ATCSA 2007 Bali Indonesia
  133. Dr Dhiren Shah – Volumetric and Functional Changes of Right Ventricle as a Predictor for Outcome after Restoring Size and Shape of Left Ventricle (SVR-surgical ventricular restoration) with CABG in Dilated Cardiomyopathy (DCM)-study of 40 cases—Oral paper presentation in IACTC2007.
  134. Goyal RK, Parikh KH, Shah HA. An Overview on the Management of Chronic Refractory Angina Pectoris. Proceedings of International Symposium on RACS 2008;135-153.
  135. Goyal RK, Parikh KH, Shah HA. First –In-Man Clinical Trials in India. CV network online 2007-08;6:44-7.
  136. Parikh KH, Shah HA. Investigational Treatments and Future Directions in Heart Failure. Investigational Treatments and Future Directions in Heart Failure. Cardiology Today 2007;12:96-103.
  137. Parikh KH, Tanna MT, Shah HA, Shah AR. Basics of Stem Cell Therapy in Heart Failure. Cardiology Today 2007-08 ;12:104-114.
  138. Parikh KH, Shah HP, Naik AM, Chag MC, Shah US,Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Rozenman Y. Effect of Metoprolol XL on pulmonary artery pressure in patients with heart failure measured using first in human implantable Device responding to ultrasonic signal. Presented in Poster session at ACC Conference on March 12, 2006. Atlanta.
  139. Parikh KH, Shah HP, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y. First in Human Implanted Device in Pulmonary Artery Using Acoustic Telemetry Based on Non-Invasive Ultrasound Activation and Communication. J Am Coll Cardiol 2006;47;1B-56B. Abstract Number: 2926-71.
  140. Parikh KH, Shah HD, Naik AM, Chag MC, Shah US, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Rozenman Y. Effect of Metaprolol XL on Diurnal variation inpulmonary arterial pressure in Heart failure patients using first-in-man implantable device responding to ultrasonic signals. Presented in Poster session at ACC Conference on March 14, 2006. Atlanta.
  141. Hetal A Shah, Ajay M Naik, Hemang A Baxi, Milan C Chag, Urmil G Shah, Anish H Chandarana, Ramesh K. Goyal, Yoseph Rozenman, Keyur H Parikh. First-in-man: effect of Metoprolol CR/XL Uptitration on Pulmonary Artery Pressure and Its Variation in Chronic Heart Failure Monitored Non-Invasively by an Implanted Device Using Ultrasonic Signals. European Heart Journal (2007) 28 (Abstract Supplement), 521.
  142. Parikh KH, Chag MC, Shah KJ, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Goyal RK. Intracoronary Boluses of Adenosine and Sodium Nitroprusside in Combination Reverses Slow/No-Reflow During Angioplasty: A Clinical Scenario of Ischemic Preconditioning. Can J Physiol Pharmacol. 2007;85(3-4):476-82.
  143. Hetal A Shah, Ajay M Naik, Hemang A Baxi, Milan C Chag, Urmil G Shah, Anish H Chandarana 2, Ramesh K. Goyal, Yoseph Rozenman, Keyur H Parikh,First-in-man: effect of Metoprolol CR/XL uptitration on pulmonary artery pressure and its variation in chronic heart failure monitored non-invasively by an implanted device using ultrasonic signals 2007
  144. Parikh KH, Chag MC, Shah KJ, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Goyal RK,2007
  145. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Iyer S, Goyal RK, Beneficial Effects Of Addition Of Fenofibrate To Statin Therapy In Patients with Acute Coronary Syndrome After Percutaneous Coronary Interventions,2007
  146. Shmuel Banai, Shmuel Ben Muvhar, Keyur H Parikh, Aharon Medina, Horst Sievert, Ashok Seth, Jonathan Tsehori, Yoav Paz, Ami Sheinfeld, Gad Keren. Coronary Sinus Reducer-Stent for the Treatment of Chronic Refractory Angina Pectoris: A Prospective, Open Label, Multi-Center Safety Feasibility First-In-Man Study. J Am Coll Cardiol 2007;49:1783-1789.
  147. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK. Efficacy of PercuSurge in Acute myocardial Infarction Patients Undergoing Revascularization With a Special Emphasis on Procedural Time. Indian Heart J 2008; 60(2):101-19.
  148. Keyur Parikh, Milan Chag, Urmil Shah, Anish Chandarana, Hemang Baxi, Satya Gupta, Ashok Seth, Pravin Chandra. First in Man: Pilot study to evaluate the safety and performance of Diamondback 360°TM Orbital Atherectomy System in treating de novo calcified coronary lesions-ORBIT I. Submitted to TCT,2008 as Late Breaking Trial.
  149. Ashok Seth, Nakul Sinha, Keyur Parikh, Tejas Patel, MS Hiremath, AB Mehta, Praveen Chandra, Brian Pinto, KK Sethi, Sengottuvelu. Safety and Efficacy of Indigenously Developed and Manufactured Bivalirudin in Moderate/High-Risk Indian Patients Undergoing Percutaneous Coronary Intervention: The Bivaflo Registry. Indian Heart J 2008;60(4):333-41.
  150. Dr Dhiren Shah – Valve Repair or Replacement –What would you choose for your dear ones?  —- Lecture at 3C Con conference 2008
  151. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK. Efficacy of PercuSurge in Acute myocardial Infarction Patients Undergoing Revascularization With a Special Emphasis on Procedural Time. Indian Heart J 2008; 60(2):101-19.
  152. Nakul Sinha, Keyur Parikh, Jaysheel B. Gangaiah, Alok Chaturvedi. Randomized, Multi-centric, Open Label Study to Evaluate Safety and Efficacy of Faximab®, A Biosimilar Abciximab in Indian Patients Undergoing Percutaneous Coronary Intervention. Submitted to Indian Heart Journal in August 2008.
  153. Yoseph Rozenman, Robert S, Schwartz, Hetal Shah, Keyur H. Parikh. Wireless Acoustic Communication with a Miniature Pressure Sensor in the Pulmonary Artery for Disease Surveillance and Therapy of Patients with Congestive Heart Failure. J Am Coll Cardiol 2007;49:784–789.
  154. Ashok Seth, Nakul Sinha, Keyur Parikh, Tejas Patel, MS Hiremath, AB Mehta, Praveen Chandra, Brian Pinto, KK Sethi, Sengottuvelu. Safety and Efficacy of Indigenously Developed and Manufactured Bivalirudin in Moderate/High-Risk Indian Patients Undergoing Percutaneous Coronary Intervention: The Bivaflo Registry. Indian Heart J 2008;60(4):333-41.
  155. Keyur H Parikh. First Report of a pilot study of orbital atherectomy in de novo calcified coronary lesions. Accepted in TCTMD in Oct. 2008 (www.tctmd.com).
  156. Keyur H Parikh. FIM Coronary CTO Results. Accepted in TCTMD in Oct. 2008 (www.tctmd.com)
  157. Keyur H Parikh. PAPIRUS Monitoring Pulmonary Artery Pressure by the Implantable Device Responding to Ultrasonic Signals-Two Year Follow Up. Accepted in TCTMD in Oct. 2008 (www.tctmd.com).
  158. Chevalier B, Gilard M, Lang I, Commeau P, Roosen J, Hanssen M, Lefevre T, Carrié D, Bartorelli A, Montalescot G, Parikh K. Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. Eurointerv 2008;4:222-228.
  159. Satya Gupta Characterization of the “vulnerable” coronary plaque by multi-detector computed tomography: a correlative study with intravascular ultrasound-derived radiofrequency analysis of plaque composition. Euro Intervention: journal of Euro PCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008;4(3):318-23.
  160. Patel HR, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA. Study to Evaluate Safety and Efficacy of Bare Metal Stent and Zotarolimus Eluting Stent. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
  161. Bhanushali SM, Patel VD Ghatak SB, Patel MV, Daniel PS, Parikh KH, Bhatt PA. To evaluate the comparative efficacy of angiotensin receptor blocker in acute coronary syndrome patients following medicated and non-medicated coronary stent implantation. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
  162. Patel VD, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA. Triple versus dual antiplatelet therapy following coronary stenting: Impact on lipid profile. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
  163. Patel JM, Patel HR, Patel MV, Ghatak SB, Anand IS, Parikh KH, Bhatt PA. Pharmacoeconomic analysis, clinical outcomes and quality of life assessment between medication therapy and drug eluting stent in single vessel blockade patients. Poster Session at the 61st Indian Pharmaceutical Congress, on Dec. 11 – 13, 2009, at the Nirma University of Science and Technology, Ahmedabad, India.
  164. Lysosomal storage disease –a rare cause of Hepatosplenomegaly. APGCON 2008 (Poster presentation).
  165. A rare case of hepatolenticular degeneration (Wilson’s disease). APGCON 2008(Poster presentation).
  166. Parikh KH, Chag Milan, Shah Anuja, Segev Amit. Ovalum CiTopTM: A Novel Guidewire for Crossing Chronic Total Occlusion – First-in-Man (FIM) Experience. EuroInterv 2009;5:206-211.
  167. Shah V, Patel T.A case of Malabsorption Syndrome (MAS) due to Tropical Sprue. JCDR. 2009 Apr; 3:1445-1448.
  168. . Shah V, Patel T.A case of Malabsorption Syndrome (MAS) due to Tropical Sprue. JCDR. 2009 Apr; 3:1445-1448.
  169. Ian Meredith, Martin Rothman, Andrejs Erglis, Keyur Parikh, Chaim Lotan. Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice: Extended 2-Year Follow-up from the E-Five Registry. J Am Coll Cardiol Intv 2009;2;1227-1235.
  170. Robert A. Harrington, Gregg W. Stone, Steven McNulty, Harvey D. White, A. Michael Lincoff, C. Michael Gibson, Charles V. Pollack, Jr., Gilles Montalescot, Kenneth W. Mahaffey, Neal S. Kleiman, Shaun G. Goodman, Maged Amine, Dominick J. Angiolillo, Richard C. Becker, Derek P. Chew, William J. French, Franz Leisch, Keyur H. Parikh, Simona Skerjanec, and Deepak L. Bhatt. Platelet Inhibition with Cangrelor in Patients Undergoing PCI. N Engl J Med 2009;361:2318-29.
  171. Edoardo Camenzind, William Wijns, Laura Mauri, cEric Boersma, Keyur Parikh, Volkhard Kurowski, Runlin Gao, Christoph Bode, John P. Greenwood, Anthony Gershlick, William O’Neil, Patrick W. Serruys, Brenda Jorissen, and Gabriel P. Steg. Rationale and Design of the Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial (PROTECT): Randomized Controlled Trial Comparing the Incidence of Stent Thrombosis and Clinical Events after Sirolimus or Zotarolimus Drug-Eluting Stent Implantation. Am Heart J 2009;158:902-909.e5.
  172. Keyur Parikh, Ashok Seth, Hemang Baxi, Anish Chandarana, Satya Gupta, Urmil Shah, Milan Chag, Sandhya Nair, Praveen Chandra, First In Man Assessment of Orbital Atherectomy System in Treating De Novo Calcified Coronary Lesions (ORBIT I),2009
  173. Keyur Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chanadarana, Ajay Naik, Satya Gupta, Shmuel Banai, Long Term Safety, Angina Relief and Improvement in Quality of Life in Patients with Refractory Angina Treated with the Neovasc Coronary Sinus Reducer,2009.
  174. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK, Rozenman Y, Hjalmarson A. Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity. Indian Heart J 2009;61:34-9.
  175. Keyur Parikh, Milan Chag, Amit Segev, Anuja Shah. FIM Study: The Ovalum CiTop Expander Guidewire for Recanalisation of Coronary CTOs. Euro Intervention 2009;5(Supplement E):E99.
  176. Parikh Keyur, Pandya Nilesh, Baxi Hemang, Chag Milan, Gupta Satya, Chandarana Anish, Naik Ajay, Shah Urmil. The Principal Investigator of ORBIT I Trial Discusses Safety and Performance of Diamondback 360° TM Orbital Atherectomy System in Treating de novo Calcified Coronary Lesions. Gujarat Medical Journal 2010;5(7):114-116.
  177. Chag Milan, Gupta Satya, Chandarana Anish, Shah Urmil, Baxi Hemang, Parikh Keyur.Transradial Interventions: Our Experience. Gujarat Medical Journal 2010;5(7):127-130.
  178. Jagdish Hiremath, S. Thanikachalam, Keyur Parikh, S. Shanmugasundaram, Sudhakar Bangera, Leland Shapiro, Gregory B. Pott Cindy L.Vnencak-Jones. Exercise Improvement and Plasma Biomarker Changes with Intravenous Treprostinil Therapy for Pulmonary Arterial Hypertension: A Placebo-Controlled Trial (TRUST – 2) The Journal of Heart and Lung Transplantation 2010;29(2):137-149.
  179. Parloop Bhatt, Manoj Patel, Somsuvra Ghatak, Keyur Parikh. Reinventing the Phases of Clinical Trial. Pharmaceutical Reviews 2010;8(1).
  180. Camenzind E, Steg PG, Parikh K, Kurowski V, Gao R, Bode C, Greenwood JP, Gershlick A, Boersma E, Mauri L, O’Neill W, Serruys PW, Wijns W. Baseline Clinical and Angiographic Characteristics of the Patient Related Outcomes WiTh Endeavor Versus Cypher STenting (PROTECT) Trial. J Am Coll Cardiol 2010;56;B64.
  181. Shmuel Banai, Marc Schwartz, Horst Sievert, Ashok  Seth, Gad Keren, Keyur H Parikh. Long Term Follow-Up to Evaluate the Safety of the Neovasc Reducer A Device-Based Therapy for Chronic Refractory Angina. J Am Coll Cardiol 2010;55;A98.E927.
  182. Hiren patel, Manoj Patel, I. S.Anand, Chaman Patel, Keyur Parikh, Parloop Bhatt. Pharmacoeconomical Comparison of Bare Metal Stent and Drug Eluting Stent. Journal of Chemical and Pharmaceutical Research 2010;2(2):73-81.
  183. Jatin Patel, Vinod Patel, Hiren Patel, Manoj Patel, Keyur Parikh, Parloop Bhatt, Chaman Patel, I. Anand. Pharmacoeconomic Analysis, Clinical Outcomes between Medication Therapy and Drug Eluting Stent in Single Vessel Blockade Patients. Deccan Journal of Pharmacology 2010; 1(1):29­42.
  184. Hiren R Patel, Vinod D Patel, IS Anand, CN Patel, Keyur Parikh, Parloop Bhatt. A Study to Compare Clinical Outcomes of Bare Metal Stent and Zotarolimus Eluting Stent. Journal of Global Pharma Technology 2010;2(3):146-153.
  185. Nanjundappa Arvind, Siddiqui Yaha, Thompson Stephanie, Parikh Keyur. Blood transfusion: Benefit or Harm? Allogenic Blood Transfusion related Mortality in the Cardiovascular Patient. Gujarat Medical Journal 2010;5(7):131-133.
  186. Keyur Parikh. Perspective. Gujarat Medical Journal 2010;5(7):138-140.
  187. Stefan James, Andrzej Budaj, Philip Aylward, Kristen K. Buck, Christopher P. Cannon, Jan H. Cornel, Robert A. Harrington, Jay Horrow, Hugo Katus, Matyas Keltai, Basil S. Lewis, Keyur Parikh, Robert F. Storey, Karolina Szummer, Daniel Wojdyla, Lars Wallentin. Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function: Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation 2010;122:1056-1067.
  188. Anjani P Upadhyay, Parloop A Bhatt, Jay J Naik, Keyur H Parikh. Approach to Therapy of Diabetic Patients with Cardiovascular Disorders. Journal of Global Pharma Technology: In Press.
  189. Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Bhatt DL, Stone GW, Lincoff MA, Dauerman HL, Gibson CM, White HD, Parikh K, Gruberg L, Herrmann HC, McLaurin BT, Goodman S, Harrington RA, and Mahaffey KW. Pre-Treatment With Thienopyridines Reduces The Amount of Myonecrosis in Acute Coronary Syndrome Patients Invasively Managed: Insights from the CHAMPION trials. Circulation, 2010;122:A14813.
  190. Keyur Parikh. Orbital Atherectomy Device: Two Year Follow-up Experience. Presented at ICI Meeting, 2010, Israel.
  191. Keyur Parikh. A Three Year’s Clinical Experience Evaluating the Safety of Neovasc Reducer for No Option Patients. Presented at ICI Meeting, 2010, Israel.
  192. Sandip Bhanushali, PS Daniel, IS Anand, CN Patel, Parloop Bhatt, Keyur Parikh. The Comparative Efficacy of Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Following Medicated and Non-medicated Stent Implantation. Journal of Global Pharma Technology 2010;2(3):98–106.
  193. Vinod Patel, J M Patel, I S Anand, C N Patel, M V Patel, Keyur Parikh, Parloop Bhatt. Triple Versus Dual Antiplatelet Therapy Following Coronary Stenting: Impact on Lipid Profile. Deccan Journal of Pharmacaology 2010;1(1):43­59.
  194. Keyur Parikh. Editorial: A Quarter Century of Direction- Femoral Approach Towards Extinction…. Indian Heart Journal 2010;62(3):191.
  195. Keyur Parikh. Guest Editorial. Gujarat Medical Journal 2010;5(7):13.
  196. Parikh Keyur, Parikh Roosha. Guidelines (and Advisory) for Doctors and surgeons) to Manage Anti-thrombotic Agents in Patients with Drug Eluting and Bare Metal Stents Undergoing Non Cardiac Surgery. Gujarat Medical Journal 2010;5(7):49-53.
  197. Dr Satya Gupta “Impact of anticoagulation on Ionic and Non Ionic Contrast Media effect on thrombogenesis and fibrinolysis: The PEPCIT Study” Sent to Arteriosclerosis, Thrombosis and Vascular Biology Journal for publication.
  198. Trans-radial Interventions: Our Experience. Indian Heart J 2010; 62:264-266.
  199. Tips and Tricks for Radial Interventions. Indian Heart J 2010; 62:275-276.
  200. Ajay Naik Several publications reputed International journals viz. Circulation, JACC, NEEJ, JCE, Heart Rhythm, CCVD etc.
  201. Satya Gupta, Abhi Patangay, Promadsingh Thakur, Elisa Vireca, Ajay Naik, Hemang Baxi, Urmil Shah, Anish Chandarana, Keyur Parikh. Third Heart Sounds Measured at CRT Device Implant Sites are Correlated to Echocardiographic Filling Parameters in Ambulatory Heart Failure Patient. 2011 HRS Abstract On TRAC HF Study.
  202. Satya Gupta, Abhi Patangay, Promadsingh Thakur, Elisa Vireca, Ajay Naik, Hemang Baxi, Urmil Shah, Anish Chandarana, Keyur Parikh. Transient Heart Rate Responses to Transitions in Posture in Ambulatory Heart Failure Patients are Correlated to BNP. Heart Failure Society of America 2011 HFSA Abstract Number – 150398.
  203. Keyur Parikh, Praveen Chandra, Apurva Patel, Milan Chag, Jeff Chambers. Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions (ORBIT I Trial). J Am Coll Cardiol 2011;58;B172-B173.
  204. Chag Milan, Panchal Kanaiya, Baxi Hemang, Chandarana Anish, Naik Ajay, Shah Urmil, Parikh Keyur.Initial Experience with CiTop™ ExPander™ Guidewire in Chronic Coronary Total Occlusion. Gujarat Medical Journal 2010;5(7):117-120.
  205. Chag Milan, Gupta Satya, Chandarana Anish, Shah Urmil, Baxi Hemang, Parikh Keyur.Transradial Interventions: Our Experience. Gujarat Medical Journal 2010;5(7):127-130.
  206. Naik Ajay, Chanadarana Anish, Chag Milan, Gupta Satya, Baxi Hemang, Shah Urmil, Parikh Keyur. Neovasc Coronary Sinus Reducer: The Time Tested Option for “No Option” Patients. Gujarat Medical Journal 2010;5(7):111-113.
  207. Chag Milan, Gupta Satya, Chandarana Anish, Shah Urmil, Baxi Hemang, Parikh Keyur, Transradial Interventions: Our Experience, Gujarat Medical Journal, Page 127, Issue-7, Volume-5, July 2010.
  208. Parikh Keyur, Naik Ajay, Gupta Satya, Baxi Hemang, Chandarana Anish, Shah URmil, Chag Milan. RemonCHF: Better Care for Congestive Heart Failure Patients. Gujarat Medical Journal 2010 Jul;5(7):109-110
  209. Keyur Parikh, Roosha Parikh, Apurva Patel, Milan Chag. Two Year Follow up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions – A Single Center Experience. J Am Coll Cardiol 2011;58;B174.
  210. Rubin L, Parikh K, Pulido T, Jerjes-Sanchez C, Allen R, White RJ, Torbicki A, Xu KF, Yehle D, Laliberte K, Arneson C, Jing ZC. FREEDOM-M: Efficacy and Safety of Oral Treprostinil Diethanolamine as Monotherapy in Patients with Pulmonary Arterial Hypertension. Chest Meeting, 26 Oct 2011.
  211. Leonardi S, Stebbins A, Lopes RD, Lokhnygina Y, Bhatt DL, Stone GW, Lincoff MA, Dauerman HL, Gibson CM, White HD, Parikh K, Gruberg L, Herrmann HC, McLaurin BT, Goodman S, Harrington RA, and Mahaffey KW. Maintenance Therapy with Thienopyridines May Reduce Enzymatic Infarct Size in Patients with Acute Coronary Syndrome Undergoing PCI: Insights from the CHAMPION PCI Trial. Circulation: In Process.
  212. Bhavik Shah, Keyur Parikh, Shailaja Mahajan. Baseline characteristics, intervention modalities and utilization of evidence based medications among ACS patients: does presence of diabetes affect the presentation as well as management scenario for ACS? – results from single centric cross-sectional study from India. Poster Presentation at ISPOR 14th Annual European Congress, 7th November, 2011.
  213. Keyur Parikh. Promise of Newer Antiplatelet Agents in PCI. Abstract Book of ICI Meeting, 5th December 2011, Israel.
  214. Keyur Parikh. Regulatory Aspects in India. Abstract Book of ICI Meeting, 5th December 2011, Israel.
  215. Keyur Parikh. Use of Extraction Devices in Acute Myocardial Infarction-Are we there or do we need More Trials? Abstract Book of ICI Meeting, 6th December 2011, Israel.
  216. Keyur Parikh, Parloop Bhatt. Correlation between Insulin Resistance and Altered Thyroid State. Abstract Accepted; CSI, 8-11 December 2011, Mumbai, India
  217. Keyur Parikh. Parloop Bhatt, JL Mehta, Abhishek Deshmukh. Correlation between Depression and Cardiovascular Disease. Abstract Accepted; CSI, 8-11 December 2011, Mumbai, India.
  218. Keyur Parikh, MD, DM, FACC, FESC, FSCAI, FAPSIC; Praveen Chandra, MD, DM, FACC, FESC, FSCAI, FAPSIC; Nishit Choksi, MD; FACC; P.K. Khanna, MD, FACC; Jeff Chambers, MD, FACC. Safety and Feasibility of Orbital Atherectomy for the Treatment of Calcified Coronary Lesions – the ORBIT I Trial. Accepted: CCI 2012.
  219. Edoardo Camenzind, William Wijns, Laura Mauri, Volkhard Kurowski, Keyur Parikh, Runlin Gao, Christoph Bode, John P Greenwood, Eric Boersma, Pascal Vranckx, Eugene McFadden, Patrick W Serruys, William W O’Neil, Brenda Jorissen, Frank Van Leeuwen, Ph Gabriel Steg, for the PROTECT Steering Committee and Investigators. Protect Trial: Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised multicentre open-label trial. Accepted: CCI 2012.
  220. Keyur Parikh: Gender Related Disparity in Cardiovascular Risk Factors and Treatment Options. Abstract Accepted: TCT 2012, Miami Beach Convention Center.
  221. Keyur Parikh: Radial Percutaneous Transluminal Angioplasty with Stenting of Celiac Artery and Suprarenal Abdominal Aorta in Ventilated Patient with Takayasu Arteritis and Severe Heart Failure. Edited Live Case-Main Session- Accepted: TCT 2012, Miami Beach Convention Center.
  222. Upendra Kaul, KK Sethi, JJ Dalal, K Parikh, M S Hiremath, AS Mullasari. TRACE: A MulTicenter Retrospective Study to understand Anti-thrombotic treatment patterns and outcomes of Acute Coronary syndrome patients in India. Accepted as an oral presentation in CSI – 2012.
  223. Keyur Parikh: Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo Calcified Coronary Lesions By Orbital Atherectomy. Accepted as Poster Presentation at CRT 2013.
  224. Sergio Leonardi, MD, MHS, Amanda Stebbins, Meredith Todd, Deepak L. Bhatt, MD, Gregg W. Stone, MD, Michael Lincoff, MD, Harold L. Dauerman,MD, C. Michael Gibson,MD,Harvey D. White, DSc, Keyur H. Parikh, MD.  “Quantification of Clopidogrel Effect on Enzymatic Infarct Size Related to Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes: Insights from the CHAMPION PCI Trial.” accepted for publication in Coronary Artery Disease
  225. Parikh K et al. – The ORBIT I trial evaluated the safety and performance of an orbital atherectomy system (OAS) for the treatment of de novo calcified coronary lesions. The ORBIT I trial suggests that the OAS may offer an effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult to treat patients. A larger trial is required to establish safety and overall effectiveness of the OAS in treating calcified coronary lesions.
  226. Satya Gupta, Keyur Parikh, Parloop Bhatt. A Prospective Study to Relate Gastrointestinal Distress with Depression and Quality of Life in Cardiovascular Disease Patients. Poster presentation at Innovations in Cardiovascular Interventions (ICI) Conference, Tel-Aviv, Israel, Dec 2012
  227. Keyur Parikh,*MD, Praveen Chandra, MD, Nishit Choksi, MD,Puneet Khanna,MD, and Jeffrey Chambers, MD-Safety and Feasibility of Orbital Atherectomy for the Treatment of Calcified Coronary Lesions:The ORBIT I Trial. Catheterization and Cardiovascular Interventions June 2013 Volume 81, Issue 7, 1134-1139.
  228. CRT-126 Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo Calcified Coronary Lesions By Orbital Atherectomy System. Keyur Parikh; Roosha Parikh; Apurva Patel; Milan Chag. Published in JACC: Published in Cardiovascular Interventions CRT 2013 Supplement: Volume 6, Number 2 S
  229. Keyur Parikh, Roosha Parikh, Apurva Patel, Milan Chag: Three Years Follow Up Data Demonstrate Safe And Effective Treatment Of De Novo Calcified Coronary Lesions By Orbital Atherectomy System. Accepted as abstract at CRT 2013, Washington DC.
  230. Roosha Parikh, Apurva Patel, Parth Parikh, Keyur Parikh, Dhaval Naik, Niren Bhavsar, Hiren Dholakia, Chintan Mehta, Neil Mehta, Parloop Bhatt, Jawahar Mehta, Dhiren Shah: A Hospital to Home Health Care Initiative for Early Follow-up, Post Discharge Management, Patient Self Care and Activation Following Coronary Artery Bypass Graft Surgery – A First Indian Pilot Study (Submitted in American College of Cardiology ACC March -2014)
  231. William Wijns, Ph. Gabriel Steg, Laura Mauri, Volkhard Kurowski, Keyur Parikh, Runlin Gao, Christoph Bode, John P. Greenwood, Erik Lipsic, Farqad Alamgir, Tessa Rademaker-Havinga, Eric Boersma, Peter Radke, Frank van Leeuwen, and Edoardo Camenzind for the PROTECT Steering Committee and Investigators- Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4 year results of the PROTECT randomized trial. Accepted and Published in European Heart Journal Advance Access published August 8, 2014
  232. George P. V., Patel T. V.Impact of cardiac magnetic resonance imaging in the management of post myocardial infarction ventricular septal rupture- a case report. Med ej. 2014 July-Aug; vol-4
  233. George P. V., Balasundaram S., Patel T.Stresshyperglycemia- an independent risk factor for multi-vessel coronary arterydisease in post myocardial infarction nondiabetic patients. -Under review in European Heart Journal
  234. Varghese M. J., Patel T. V., George P. V., Pati P. K. & Jose V. J. Mammoth Right Atrium. J. Am. Coll. Cardiol. 63, e21 (2014).
  235. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Chintan Mehta, Neil Mehta, Jawahar Mehta, Parloop Bhatt, Keyur Parikh: A Hospital to Home Visit Model to Ensure Medical Compliance and Reduce Complications Following Percutaneous Coronary Intervention: A Novel Global Concept. Accepted as a presentation at the SCAI 2014
  236. Niren Bhavsar, Roosha Parikh, Apurva Patel, Parth Parikh, Satya Gupta, Dhaval Naik, Chintan Mehta, Parloop Bhatt, Keyur Parikh, Dhiren Shah: Comparative Safety and Efficacy Evaluation of Ivabradine, Metoprolol and its Combination in Management of Inappropriate Sinus Tachycardia in Coronary Artery Bypass Graft patients. (Submitted in American College of Cardiology ACC March -2014)
  237. Roosha Parikh, Apurva Patel, Shmuel Banai, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Ajay Naik, Satya Gupta, Vineet Sankhla, Parloop Bhatt, Keyur Parikh: A Possible Alternative Percutaneous Treatment for Patients with Disabling No-Option Angina: “Neovasc” Coronary Sinus Reducer Assessment – 8 Year Follow Up. Accepted as a poster presentation at the SCAI 2014
  238. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Parloop Bhatt, Keyur Parikh: Orbital Atherectomy System in Treating Calcified Coronary Lesions: First in Man Assessment- 5 Year Follow Up. Accepted as a poster presentation at the SCAI 2014.
  239. Roosha Parikh, Apurva Patel, Parth Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Piyush Thakar, Jawahar Mehta, Parloop Bhatt, Vineet Sankhla, Keyur Parikh: Increasing Penetration of Drug Eluting Stents in Developing Countries – A Single Center 10 year Study (Submitted in American College of Cardiology ACC March -2014)
  240. Parloop Bhatt, Apurva Patel, Roosha Parikh, Parth Parikh, Aditi Patel, Satya Gupta, Jawahar Mehta, Wafia Eteiba, Sharon Mulvagh, Giuseppe Ambrosio, Naranjan Dhalla, James Willerson, Keyur Parikh: International Task Force for Prevention of Cardiovascular Disease: Determining Factors to Assess Primary Prevention Outcomes in Western India (Submitted in American College of Cardiology ACC March -2014)
  241. Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh: Orbital Atherectomy System in Treating Calcified Coronary Lesions: 3-Year Follow-Up in First Human Use Study (ORBIT I Trial). Accepted as a publication Cardiovascular Revascularization Medicine, Vol. 15, Issue 4.
  242. Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Keyur Parikh. Novel First in man use of first ever sirolimus Drug Coated Balloon in carotid instent restenosis. (Accepted as a Poster Presentation in American College of Cardiology ACC March -2015)
  243. Parloop Bhatt, Aditi Patel, Parth Parikh, Jawahar Mehta, Piyush Thakar, Aditi Nanavati, Roosha Parikh, Apurva Patel, Keyur Parikh. Depression and Outcome of Patients with Acute Coronary Syndrome: A 3 Year Follow-up Study. (Accepted as a Poster Presentation in American College of Cardiology ACC March -2015)
  244. Parth Parikh, Aditi Patel, Parloop Bhatt, Apurva Patel, Roosha Parikh, Keyur Parikh. A Comparative Study Of Risk Factors And Age of Revascularization In Indian ( Asian) Patients With Coronary Artery Disease . (Submitted in American College of Cardiology ACC March -2015)
  245. Parloop Bhatt, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Jawahar L. Mehta, Keyur Parikh: Unique Aspects of Coronary Artery Disease in Indian Women Abstract Accepted; Cardiovascular Drug & Therapy, 26th May 2015, by Springer.
  246. Comparative study of serum procalcitonin level in STEMI patients undergoing primary. PTCA v/s thrombolysis & to correlate with in-hospital and 30days outcomes -abstract sent for European Society of Cardiology Congress 2015
  247. Exclusive CO2 angiography and bilateral renal artery stenting in a rare presentation of Takayasu arteritis -selected for challenging case presentation in INDIA LIVE 2015
  248. Patel T., Devi A. Prosthesis endocarditis after a Rastelli operation. -Under review in New England Journal of Medicine
  249. Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Anish Chandarana, Parloop Bhatt, Milan Chag, Satya Gupta, Hemang Baxi, Vineet Sankhla, Piyush Thakar, Aditi Nanavati, Urmil Shah, Keyur Parikh. Bioresorbable Scaffolds: An Alternative to Newer Generation Drug Eluting Stents in patients with Multi-Lesion Multi vessel Coronary Artery Disease (Submitted in American College of Cardiology ACC March -2015)
  250. Aditi Patel, Parth Parikh, Roosha Parikh, Apurva Patel, Parloop Bhatt, Aditi Nanavati, Piyush Thakar, Ajay Naik, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Keyur Parikh. Prevalence, Assessment and Clinical Outcome in Cardiovascular Disease: Gender Disparities in Indian Population. (Submitted in American College of Cardiology ACC March -2015)
  251. Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Anish Chandarana, parloop bhatt, Milan Chag, Urmil Shah, Hemang Baxi, Satya Gupta, Vineet Sankhla, Keyur Parikh. Drug Coated Balloon: A Safe and innovative application with a new first Sirolimus Drug Coated Balloon (DCB)-Magic TouchTM for complex Coronary Artery Disease with In-stent restenosis, bifurcation disease and small vessel disease. (Submitted in American College of Cardiology ACC March -2015)
  252. Parloop Bhatt, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Hemang Baxi, Urmil Shah, Ajay Naik, Satya Gupta, Sankhla Vineet, Dhiren Shah, Aditi Nanavati, Piyush Thakar, Kinjal Shah, Keyur Parikh. Modeling the Treatment Burden of Young Coronary Artery Disease in India. (Submitted in American College of Cardiology ACC March -2015)
  253. Keyur Parikh, Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Hemang Baxi, Sirolimus Drug Coated Balloon (DCB): A Novel Approach In Treatment Of Below The Knee Lesions in Critical Limb Ischemia With First Ever Sirolimus Drug Coated Balloons. (Submitted in American College of Cardiology ACC March -2015)
  254. Poonam Chodvadiya, Keyur Parikh, Ranjan Shetty, Sameer Dani, N. Prathapkumar: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Result from the Nanolute Registry Abstract Accepted: TCT 388 Journal of The American College of Cardiology Vol 68. No 18 Suppl 8, 2016
  255. Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh: Long-term Safety and Performance of the Orbital Atherectomy System for Treating Calcified Coronary Artery Lesions: 5-Year Follow-Up in the ORBIT I Trial
    Cardiovascular Revascularization Medicine. (Accepted as a publication Cardiovascular Revascularization Medicine 2016, S1553-8389 (15) 00091-3
  256. Milan Chag, Parloop Bhatt, Urmil Shah, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Aditi Nanavati, Piyush Thakar, Keyur Parikh. Hospital to Home Visit, an Effective Health Care Initiative to Reduce Complications and Improve Drug Compliance and Adherence: NCDR® Participation Advantage. Accepted in NCDR 2016.
  257. Urmil  Shah,  Milan  Chag,  Dhiren  Shah,  Ajay  Naik,  Hemang  Baxi,  Anish  Chandarana, Satya Gupta, Vineet Sankhla, Keyur Parikh, Parloop Bhatt. NCDR® as a Resource to Develop Cardiac Disease Specific Clinical Care Clinics. Accepted in NCDR 2016.
  258. Urmil Shah, Milan Chag, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Keyur Parikh, Parloop Bhatt. An Asian Indian Single Centre Radial Access Percutaneous Coronary  Intervention Experience: NCDR® Findings. Accepted in NCDR 2016.
  259. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Roosha Parikh, Apurva Patel, Aditi Nanavati, Piyush Thakar, Jawahar Mehta, Keyur Parikh. Depression Adversely Affects Long Term Outcomes in Acute Coronary Syndrome Patients: A Real World Scenario. Accepted in SCAI 2016.
  260. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Vatsal Chhaya, Anish Chandarana, Hemang Baxi, Urmil Shah, Dhiren Shah, Ajay Naik, Keyur Parikh. Temporal Trends in Young Indian Heart Failure Patients: A Ray of Hope. Accepted in SCAI 2016.
  261. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Apurva Patel, Aditi Nanavati, Anish Chandarana, Hemang Baxi, Keyur Parikh. Effect of Mono-therapy versus Combinational Therapy on Exercise Capacity of Pulmonary Arterial Hypertension Patients: Actual Care Data. Accepted in SCAI 2016.
  262. Satya Gupta, Parloop Bhatt, Milan Chag, Nairuti Trivedi, Keyur Parikh, Apurva Patel, Roosha Parikh, Parth Parikh, Aditi Patel, Jawahar Mehta, Dhiren Shah. Chest Pain in Acute Coronary Syndrome Patients with Depression after Bypass Surgery. Accepted in SCAI 2016.
  263. Satya Gupta, Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Anish Chandarana, Milan Chag, Hemang Baxi, Urmil Shah, Keyur Parikh. Sustained Long Term Safety Outcomes of “NEOVASC” Coronary Sinus Reducer in No-Option Patients of Refractory Angina: 10 Year Follow-up Accepted in SCAI 2016.
  264. Parth Parikh, Apurva Patel, Parloop Bhatt, Milan Chag, Roosha Parikh, Anish Chandarana, Hemang Baxi, Satya Gupta, Vipul Kapoor, Vineet Sankhla, Keyur Parikh, Care Institute Medical Sciences, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Evaluation of a New Radiation Protection Technology (Cardio-TRAP®) in Transradial Percutaneous Coronary Intervention Procedures Abstract Accepted: at ACC March 2017
  265. Parth Parikh, Parloop Bhatt, Vipul Kapoor, Hemang Baxi, Satya Gupta, Tejas Patel, Anish Chandarana, Roosha Parikh, Apurva Patel, Keyur Parikh, Cleveland Clinic, Care Institute of Medical Sciences (CIMS) Optimal P2Y12 Inhibitors for Primary Percutaneous Coronary Intervention Patients in ST Segment Elevation Myocardial Infarction: Actual Care Trends and Outcomes (Accepted at the SCAI 2017 Scientific Sessions in New Orleans, LA May 10 – 13, 2017)
  266. Parloop Bhatt, Parth Parikh, Ajay Naik, Milan Chag, Vineet Sankhla, Dhiren Shah, Dhaval Naik, Sophy Patel, Khushbu Thakkar, Neil Jain, Aenasha Chag, Zarna Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: Impact of Diabetes on Treatment and Outcomes of Patients With Heart Failure: Heart Failure Clinic Analysis (Submitted in American College of Cardiology ACC March -2018)
  267. Keyur H. Parikh, Parth Parikh, Parloop Bhatt, Satya Gupta, Hemang Baxi, Urmil Shah, Tejas Patel, Milan Chag, Sameer Dani, Ranjan Shetty, Prathap Kumar, Jagdish Hiremath, Dinesh Shah, Manish Doshi, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland Clinic, India: Prospective Real World Registry for the Use of Sirolimus Coated Balloon in Small Vessel De Novo Lesions (Accepted in American College of Cardiology ACC March -2018)
  268. Parloop Bhatt, Parth Parikh, Aditi Nanavati, Zarana Patel, Palak Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: ST-segment Elevation Myocardial Infarction In Women With Type 2 Diabetes Mellitus(Submitted in American College of Cardiology ACC March -2018)
  269. Parloop Bhatt, Parth Parikh, Hemang Baxi, Urmil Shah, Satya Gupta, Tejas Patel, Shreyasharlet John, Aenasha Chag, Palak Patel, Aditi Nanavati, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: Clinical Research Participant Satisfaction Analysis Outcomes: A Prospective Study in a Developing Nation Cardiology Center (Submitted in American College of Cardiology ACC March -2018)
  270. Parloop Bhatt, Parth Parikh, Anish Chandarana, Milan Chag, Vipul Kapoor, Aditi Nanavati, Tejas Patel, Satya Gupta, Hemang Baxi, Urmil Shah, Vineet Sankhla, Neil Jain, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India: Impact of Drug Eluting Stent Price Reduction in India:Selection for Stent Type Placement and Associated Outcomes (Accepted in American College of Cardiology ACC March -2018)
  271. Keyur H. Parikh, Parth Parikh, Parloop Bhatt, Aenasha Chag, Hemang Baxi, Milan Chag, Urmil Shah, Satya Gupta, Anish Chandarana, Manish Doshi, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Real World Clinical Outcomes of Sirolimus Coated Balloon in Coronary Artery Lesions: Results from Single Centre Study(Accepted in American College of Cardiology ACC March -2018)
  272. Keyur H. Parikh, Parth Parikh, Deepa Shah, Parloop Bhatt, Piyush Thakar, Ajay Naik, Hemang Baxi, Shmuel Banai, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Coronary Sinus ReducerTM Retains Patency and Efficacy at Twelve Years: A Prospective Cardiac CT Angiography Outcomes(Accepted in American College of Cardiology ACC March -2018)
  273. Patel B Krunal, Chag C Milan, Gupta B Satya, Bhatt A Parloop, Parikh K Parth, Patel Aditi, Patel K Apurva, Jain N Neil, Parikh H Keyur, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: FIRST IN MAN VASCULAR USE OF AXIOSTAT®: A NOVEL WHOLE CHITOSAN HAEMOSTATIC DRESSING FOR TRANSRADIAL CORONARY INTERVENTION Accepted: At WEC, Rajasthan, India, October, 2017
  274. Parikh K Parth, Patel B Krunal,Chag C Milan, Gupta B Satya, Bhatt A Parloop, Parikh K Parth, Patel Aditi , Patel K Apurva, Jain N Neil, Parikh H Keyur, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: SUPERIORITY OF NEWER ORAL P2Y12 INHIBITORS IN TREATMENT IN CORONARY ARTERY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION AT A HIGH VOLUME NON-US CENTER Abstract Accepted: at WEC, Rajasthan, India, October, 2017
  275. Parloop Bhatt, Parth Parikh, Ajay Naik, Milan Chag, Vineet Sankhla, Dhiren Shah, Dhaval Naik, Sophy Patel, Khushbu Thakkar, Neil Jain, Aenasha Chag, Zarna Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India, Impact of Diabetes on Treatment and Outcomes of Patients With Heart Failure: Heart Failure Clinic Analysis Abstract submitted at SCAI 2018
  276. Parloop Bhatt, Parth Parikh, Aditi Nanavati, Zarana Patel, Palak Patel, Piyush Thakar, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India ST-segment Elevation Myocardial Infarction In Women With Type 2 Diabetes Mellitus Abstract submitted at SCAI 2018
  277. Parloop Bhatt, Parth Parikh, Hemang Baxi, Urmil Shah, Satya Gupta, Tejas Patel, Shreyasharlet John, Aenasha Chag, Palak Patel, Aditi Nanavati, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy, Ahmedabad, India Clinical Research Participant Satisfaction Analysis Outcomes: A Prospective Study in a Developing Nation Cardiology Center Abstract submitted at SCAI 2018
  278. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh NCDR® as a Resource Improvement in Hospital Quality Parameters Abstract Accepted at NCDR 2018
  279. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Achieving Highest Benchmarks in Interventional Cardiology: NCDR® Cath PCI a Critical Contributing Factor Abstract Accepted at NCDR 2018
  280. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Reduced Median Fluoro Time: An Outcome of NCDR®  Participation Abstract Accepted at NCDR 2018
  281. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Reduced Percutaneous Coronary Intervention In-hospital Risk Adjusted Rate of Mortality And Bleeding Events via Radial Access: NCDR® Findings Abstract Accepted at NCDR 2018
  282. Dhiren Shah, Milan Chag, Deepa Shah, Dhaval Naik, Amit Chandan, Chintan Sheth, Niren Bhavsar, Hiren Dholakiya, Parloop Bhatt Late Coronary Stent Infection: A Difficult to Diagnose Rare Complication after Percutaneous Coronary Intervention Manuscript Accepted at Indian Journal of Thoracic and Cardiovascular Surgery (IJTC-D-18-00066R1) 2018.
  283. Keyur H. Parikh, Sameer Dani, Ranjan Shetty, Prathap Kumar, J.S.Hiremath, Dinesh Shah :
  284.  Sirolimus Coated Balloon For the Treatment of Coronary Artery Stenosis: Long Term 

     Outcome From a Real World Experience (Abstract Accepted in American College of 

     Cardiology ACC March -2018)

    1. Keyur H. Parikh, Sameer Dani, Ranjan Shetty, Prathap Kumar, J.S.Hiremath, Dinesh Shah : 

     Treatment of Coronary In-Stent Restenosis With Sirolimus Coated Balloon Catheter: Sub- 

     Analysis Results From Nanolute Study (Abstract Accepted in American College of 

     Cardiology ACC March -2018)

    1. Keyur H. Parikh, Clinical efficacy and safety of Sirolimus coated balloon in a real world 

     single center registry of Indian population (Abstract Accepted at EURO PCR May 2018)

    1. Keyur Parikh PTCA to significant diseased LCX: Achallenge ( Abstarct/Challenging Case 

     Accepted at TCT 2018)

    1. Banai, and Keyur Parikh, “First-in-Human Use of Coronary Sinus Reducer in Refractory Parth Parikh, Parloop Bhatt, Deepa Shah, Piyush Thakar, Ajay Naik, Hemang Baxi, Shmuel 

     Angina: 12 Years Anatomical and Clinical Outcomes” (Manuscript submitted at JACC 2018) 288. Milan Chag, Parloop Bhatt, Piyush Thaker, Keyur Parikh ‘Percutaneous Closure of Radial 

     Artery Access Site using Axiostat® Chitosan Haemostatic Dressing’ (Manuscript submitted at 

     Indian Heart Journal 2019)

    1. Keyur H. Parikh, Parloop Bhatt, Deepa Shah, Aditi Nanavati, Tejas Patel, Neil Jain No 

     Association between Hematological Indices and Coronary Calcification in Symptomatic 

     Patients of Coronary Artery Disease (Submitted in American College of Cardiology ACC 

     March -2019)

    1. Keyur H. Parikh, Parloop Bhatt, Aditi Nanavati, Piyush Thakar, Tejas Patel, Neil Jain, Parth 

     Parikh Blood Cell Count and its Elements as Risk and Outcome Predictors for Acute Coronary 

     Syndrome: A Finding from 30,216 Subjects in Real World (Submitted in American College of 

     Cardiology ACC March -2019)

    1. Keyur H. Parikh, Parloop Bhatt, Aditi Nanavati, Piyush Thakar, Tejas Patel, First-in- 

     Human Use of Orbital Atherectomy System for Treatment of Calcified Coronary Lesions: 

     ORBIT-I Single Center 10 Years Clinical Outcomes (Submitted in American College of 

     Cardiology ACC March -2019)

    292.R. James White, Keyur Parikh, Roblee Allen, Jeremy Feldman, Carlos Jerjez-Sanchez, Lei 

     Pan, Anne Keogh, C. Dario Vizza, Shelley Shapiro, Kathryn Gordon, Meredith Broderick, Sonja 

     Bartolome Long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, 

     tolerability and pharmacokinetics (Accepted at Pulmonary Circulation 2019).

 

 

 

Forms

Organ Donation Registration Form
Job Application Form

Your vote counts at CIMS Hospital, so here is our monthly question to you on whether or not the hospital should offer free internet to it's guests or whether it's not needed since everyone has an internet connection on their phone.

Do certifications like NABH, NABL or JCI help give you confidence in a hospital ?

How important is free internet (wifi) in a hospital ?

CIMS Hospital was awarded being the best hospital in Gujarat for 2019 by the International Health Care Awards.

CIMS Hospital is a 350-bedded, multi-super speciality and regarded one of the best multi-speciality hospitals of Ahmedabad in Gujarat providing a range of diagnostic and treatment services.

CIMS Hospital has been awarded best hospital for quality in service delivery award at the ABP News presents Healthcare Leadership Awards 2015 held at Mumbai.

CIMS Hospital has been recognized as the Times Health Icon 2018 for being the best Hospital for Oncology and Critical Care. CIMS Hospital also was rated the Best Multispecialty Hospital in Gujarat at the International Healthcare Awards, 2018 held in Delhi.

CIMS Hospital provides world-class treatment and healthcare services in India and the leading heart hospital in Ahmedabad, Gujarat. CIMS Hospital offers the highest quality services and offers treatment to most diseases and medical problems with one of the highest success rates in India.

CIMS Hospital
Care Institute of Medical Sciences
Off Science City Road, Sola, Ahmedabad – 380060
Gujarat, INDIA

24x7 Helpline +91 70 69 00 00 00
Phone: +91 79 2771 2771 or 72
Fax: +91 79 2771 2770
Mobile: +91 98250 66664 or +91 98250 66668
Ambulance: +91 98244 50000
Email: info@cims.org